US20090062909A1 - Stent with polymer coating containing amorphous rapamycin - Google Patents
Stent with polymer coating containing amorphous rapamycin Download PDFInfo
- Publication number
- US20090062909A1 US20090062909A1 US11/995,685 US99568506A US2009062909A1 US 20090062909 A1 US20090062909 A1 US 20090062909A1 US 99568506 A US99568506 A US 99568506A US 2009062909 A1 US2009062909 A1 US 2009062909A1
- Authority
- US
- United States
- Prior art keywords
- rapamycin
- stent
- coating
- polymer coating
- peva
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- PNVGTWKBECNTAB-KUAAOETGSA-N CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC3[C@H](C[C@@H]4CC[C@@H](O)[C@H](OC)C4)[C@H](CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C)OC(=O)[C@H]32 Chemical compound CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC3[C@H](C[C@@H]4CC[C@@H](O)[C@H](OC)C4)[C@H](CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C)OC(=O)[C@H]32 PNVGTWKBECNTAB-KUAAOETGSA-N 0.000 description 1
- 0 C[C@](CC1)[C@@](C(C(*(CCCC2C(C[C@](CC[C@]3O)C[C@]3OC)[C@](CC(CC=C(C)[C@]([C@]3OC)O)=O)O4)[C@@]2C4=O)=O)=O)(O)O[C@@]1CCC(C)=CC=CC=C[C@@](C)C[C@@](C)C3=O Chemical compound C[C@](CC1)[C@@](C(C(*(CCCC2C(C[C@](CC[C@]3O)C[C@]3OC)[C@](CC(CC=C(C)[C@]([C@]3OC)O)=O)O4)[C@@]2C4=O)=O)=O)(O)O[C@@]1CCC(C)=CC=CC=C[C@@](C)C[C@@](C)C3=O 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/821—Ostial stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
Definitions
- DES drug eluting stents
- Such localized delivery of these agents avoids the problems of systemic administration, which may be accompanied by unwanted effects on other parts of the body, or because administration to the afflicted body part requires a high concentration of pharmaceutical or biological agent that may not be achievable by systemic administration.
- the coating may provide for controlled release, including long-term or sustained release, of a pharmaceutical or biological agent.
- biomedical implants may be coated with materials to provide beneficial surface properties, such as enhanced biocompatibility or lubriciousness.
- the present invention provides a coated coronary stent comprising: a stainless steel sent framework coated with a primer layer of Parylene C; and a rapamycin-polymer coating having substantially uniform thickness disposed on the stent framework, wherein the rapamycin-polymer coating comprises polybutyl methacrylate (PBMA), polyethylene-co-vinyl acetate (PEVA) and rapamycin, wherein substantially all of the rapamycin in the coating is in amorphous form and substantially uniformly dispersed within the rapamycin-polymer coating.
- PBMA polybutyl methacrylate
- PEVA polyethylene-co-vinyl acetate
- rapamycin rapamycin
- the invention provides coated stents, wherein rapamycin is in the form of particles having an average diameter from 2 nm to 500 nm.
- the invention provides coated stents, wherein the rapamycin-polymer coating has a thickness of about 1 to about 30 microns.
- the coating is preferably substantially free of solvent residue.
- the invention provides a coated stent, wherein the rapamycin-polymer coating is sintered in dense carbon dioxide at a temperature of about 40 C to about 60 C, whereby bulk properties and adhesion of the coating to the stent are improved without altering the quality of the rapamycin, PBMA or PEVA.
- the rapamycin-polymer coating covers substantially the entire surface of the stent framework and/or the rapamycin-polymer coating is substantially free of aggregated particles.
- the invention provides a stent coated with a polymer and rapamycin comprising: a stainless steel stent framework coated with a primer layer of Parylene C; and a rapamycin-polymer coating disposed on the stent framework, wherein the rapamycin-polymer coating comprises PBMA, PEVA; and rapamycin substantially uniformly dispersed within the rapamycin-polymer coating, wherein substantially all of rapamycin in the coating is in amorphous form, wherein disposing the coating is carried out by a spray coating process whereby rapamycin spray particles are formed by rapid expansion of a supercritical or near critical fluid mixture, and the rapamycin spray particles and the stent framework are oppositely charged so that the spray particles are electrostatically attracted to the stent framework.
- the spray coating process is carried out under RESS condition.
- the supercritical or near critical fluid mixture preferably comprises PBMA, PEVA and rapamycin dissolved in dimethylether, chlorofluorocarbon, hydrofluorocarbon, carbon dioxide or mixtures thereof.
- FIG. 1 Rapid Expansion of Supercritical Solutions (RESS) process equipment see C. Domingo et al, Journal of Supercritical Fluids 10, 39-55 (1997)
- FIG. 2 Infrared spectra of each component and the spray coating mixture. Individual peaks for each component are labeled.
- FIG. 3 Stents coated (top panel) and sintered under different conditions (lower two panels) with rapamycin, PEVA and PBMA. All stent surfaces are coated
- FIG. 4 Infrared spectra with all components coated, before and after sintering. The spectra indicate that no damage is done to the coating during the sintering process.
- FIG. 5 XRD for RESS sprayed and as received rapamycin.
- the RESS sprayed rapamycin does not show any diffraction peaks indicating the RESS sprayed material is in amorphous form
- Compressed fluid refers to a fluid of appreciable density (e.g., >0.2 g/cc) that is a gas at standard temperature and pressure.
- Supercritical fluid refers to a compressed fluid under conditions wherein the temperature is at least 80% of the critical temperature of the fluid and the pressure is at least 50% of the critical pressure of the fluid.
- substances that demonstrate supercritical or near critical behavior suitable for the present invention include, but are not limited to carbon dioxide, isobutylene, ammonia, water, methanol, ethanol, ethane, propane, butane, pentane, dimethyl ether, xenon, sulfur hexafluoride, halogenated and partially halogenated materials such as chlorofluorocarbons, hydrochlorofluoro carbons, hydrofluorocarbons, perfluorocarbons (such as perfluoromethane and perfluoropropane, chloroform, trichloro-fluoromethane, dichloro-difluoromethane, dichloro-tetrafluoroethane) and mixtures thereof.
- chlorofluorocarbons such as chlorofluorocarbons, hydrochlorofluoro carbons, hydrofluorocarbons, perfluorocarbons (such as perfluoromethane and perfluoropropane, chloroform, trich
- “Sintering” as used herein refers to the process by which the polymer or polymers form continuous coating by treatment of the coated substrate with a densified gas, compressed fluid, compressed gas, near critical fluid or supercritical fluid that is a non-solvent for both the polymer and the pharmaceutical agent and biological agents, but an agent that induces formation of continuous domains of polymer.
- a densified gas, compressed fluid, compressed gas, near critical fluid or supercritical fluid that is a non-solvent for both the polymer and the pharmaceutical agent and biological agents, but an agent that induces formation of continuous domains of polymer.
- Rapid Expansion of Supercritical Solutions involves the dissolution of a polymer into a compressed fluid, typically a supercritical fluid, followed by rapid expansion into a chamber at lower pressure, typically near atmospheric conditions.
- the atmosphere of the chamber is maintained in an electrically neutral state by maintaining an isolating “cloud” of gas in the chamber. Carbon dioxide or other appropriate gas is employed to prevent electrical charge is transferred from the substrate to the surrounding environment.
- Electrostatic capture refers to the collection of the spray-produced particles upon a substrate that has a different electrostatic potential than the sprayed particles.
- the substrate is at an attractive electronic potential with respect to the particles exiting, which results in the capture of the particles upon the substrate. i.e. the substrate and particles are oppositely charged, and the particles transport through the fluid medium of the capture vessel onto the surface of the substrate is enhanced via electrostatic attraction. This may be achieved by charging the particles and grounding the substrate or conversely charging the substrate and grounding the particles, or by some other process, which would be easily envisaged by one of skill in the art of electrostatic capture.
- Open vessel refers to a vessel open to the outside atmosphere, and thus at substantially the same temperature and pressure as the outside atmosphere.
- “Closed vessel” as used herein refers to a vessel sealed from the outside atmosphere, and thus may be at significantly different temperatures and pressures to the outside atmosphere. Rapamycin is an immunosuppressive lactam macrolide that is produced by Streptomyces hygroscopicus , and having the structure depicted in Formula:
- the present invention provides a coated coronary stent comprising: a stainless steel sent framework coated with a primer layer of Parylene C; and a rapamycin-polymer coating having substantially uniform thickness disposed on the stent framework, wherein the rapamycin-polymer coating comprises polybutyl methacrylate (PBMA), polyethylene-co-vinyl acetate (PEVA) and rapamycin, wherein substantially all of the rapamycin in the coating is in amorphous form and substantially uniformly dispersed within the rapamycin-polymer coating.
- PBMA polybutyl methacrylate
- PEVA polyethylene-co-vinyl acetate
- the PBMA, PEVA and rapamycin are present in a ratio of about 1:1:1.
- the invention provides coated stents, wherein rapamycin is in the form of particles having an average diameter from 2 nm to 500 nm.
- the invention provides coated stents, wherein the rapamycin-polymer coating has a thickness of about 1 to about 30 microns.
- the coating is preferably substantially free of solvent residue.
- the invention provides a coated stent, wherein the rapamycin-polymer coating is sintered in dense carbon dioxide at a temperature of about 40 C to about 60 C, whereby bulk properties and adhesion of the coating to the stent are improved without altering the quality of the rapamycin, PBMA or PEVA.
- the rapamycin-polymer coating covers substantially the entire surface of the stent framework.
- the invention encompasses embodiments wherein the rapamycin-polymer coating is substantially free of aggregated particles.
- the invention also provides a stent coated with a polymer and rapamycin comprising: a stainless steel stent framework coated with a primer layer of Parylene C; and a rapamycin-polymer polymer coating disposed on the stent framework, wherein the rapamycin-polymer coating comprises PBMA, PEVA; and rapamycin substantially uniformly dispersed within the rapamycin-polymer coating, wherein substantially all of rapamycin in the coating is in amorphous form, wherein disposing the coating is carried out by a spray coating process whereby rapamycin spray particles are formed by rapid expansion of a supercritical or near critical fluid mixture, and the rapamycin spray particles and the stent framework are oppositely charged so that the spray particles are electrostatically attracted to the stent framework.
- the spray coating process is carried out under RESS condition.
- the supercritical or near critical fluid mixture preferably comprises PBMA, PEVA and rapamycin dissolved in dimethylether, chlorofluorocarbon, hydrofluorocarbon, carbon dioxide or mixtures thereof.
- FIG. 1 The RESS process equipment used in the present studies is depicted in FIG. 1 . This is a common design for a RESS apparatus see C. Domingo et al, Journal of Supercritical Fluids 10, 39-55 (1997).
- a solution containing rapamycin that is saturated in a solvent or supersaturated in a solvent is sprayed at a flow rate sufficient to achieve flow into a chamber of known volume pressurized above ambient pressure and containing a coronary stent.
- the system temperature is held constant or allowed to vary so that any number of points in the phase diagrams of the solution or mixture or any of its individual components can be mapped in pressure-temperature, volume-pressure or pressure-volume space constituting liquid, gas or supercritical CO 2 conditions.
- CO 2 in any single phase or combination of phases flows through the chamber at a mass flow rate of 5 gm/min to some multiple of this flow rate.
- the solute and solvent flow that is a solution of the therapeutic compound and suitable solvent for the chosen solute or solutes cease but CO 2 flow continues for an additional period of time maintaining constant pressure during this period. After this time period, the pressure is dropped to atmospheric pressure.
- the particles are attracted to the stent by charging the substrate oppositely to that of the sprayed particle charge by applying a voltage that is greater than 5000 V but less than the ionization potential of the most easily ionized component of the mixture.
- the particles may also traverse an electromagnetic field such that the field is used to guide the particle to a target.
- the individual bands used for compositional analysis were determined by spray coating Si wafer chips with each component separately.
- the coating thickness was determined gravimetrically and calculated from the density of the materials. It was assumed that the layer is fully dense. The thickness can be controlled by varying the spray time.
- the coating In the as sprayed state, the coating lacks strong adhesion to the substrate. Sintering the coated substrate (see FIG. 3 ) dramatically improves coating adhesion while leaving the components unaltered as the infrared spectra shown in FIG. 4 confirm.
- the coating is sintered in a supercritical carbon dioxide environment allowing mild sintering conditions to be used with temperature below 80 C.
- FIG. 4 shows Infrared spectra with all components coated, before and after sintering.
- the spectra indicate that no damage is done to the coating during the sintering process.
- the spectra demonstrate that the sintering process does not adversely impact the coating since no new stretches appear in the after sintering spectrum.
- FIG. 5 shows XRD data taken for an authentic rapamycin sample (as received rapamycin) and RESS sprayed rapamycin.
- the RESS sprayed rapamycin does not show any diffraction peaks indicating the RESS sprayed material is in amorphous form. In other words, the RESS sprayed rapamycin lacks any crystallinity as indicated by the absence of diffraction peaks in the XRD.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/995,685 US20090062909A1 (en) | 2005-07-15 | 2006-07-14 | Stent with polymer coating containing amorphous rapamycin |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69965005P | 2005-07-15 | 2005-07-15 | |
US76533906P | 2006-02-03 | 2006-02-03 | |
US11/995,685 US20090062909A1 (en) | 2005-07-15 | 2006-07-14 | Stent with polymer coating containing amorphous rapamycin |
PCT/US2006/027322 WO2007011708A2 (fr) | 2005-07-15 | 2006-07-14 | Stent a revetement polymere renfermant de la rapamycine amorphe |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/027322 A-371-Of-International WO2007011708A2 (fr) | 2005-07-15 | 2006-07-14 | Stent a revetement polymere renfermant de la rapamycine amorphe |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/718,342 Continuation US10835396B2 (en) | 2005-07-15 | 2015-05-21 | Stent with polymer coating containing amorphous rapamycin |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090062909A1 true US20090062909A1 (en) | 2009-03-05 |
Family
ID=37669386
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/995,685 Abandoned US20090062909A1 (en) | 2005-07-15 | 2006-07-14 | Stent with polymer coating containing amorphous rapamycin |
US14/718,342 Active US10835396B2 (en) | 2005-07-15 | 2015-05-21 | Stent with polymer coating containing amorphous rapamycin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/718,342 Active US10835396B2 (en) | 2005-07-15 | 2015-05-21 | Stent with polymer coating containing amorphous rapamycin |
Country Status (2)
Country | Link |
---|---|
US (2) | US20090062909A1 (fr) |
WO (1) | WO2007011708A2 (fr) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080095919A1 (en) * | 2006-10-23 | 2008-04-24 | Mcclain James B | Holder For Electrically Charging A Substrate During Coating |
US20090123515A1 (en) * | 2005-07-15 | 2009-05-14 | Doug Taylor | Polymer coatings containing drug powder of controlled morphology |
US20090186069A1 (en) * | 2006-04-26 | 2009-07-23 | Micell Technologies, Inc. | Coatings Containing Multiple Drugs |
US20090292351A1 (en) * | 2008-04-17 | 2009-11-26 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
US20100015200A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug Delivery Medical Device |
US20100030261A1 (en) * | 2006-10-02 | 2010-02-04 | Micell Technologies, Inc. | Surgical Sutures Having Increased Strength |
US20100063580A1 (en) * | 2007-01-08 | 2010-03-11 | Mcclain James B | Stents having biodegradable layers |
US20100211164A1 (en) * | 2007-04-17 | 2010-08-19 | Mcclain James B | Stents having biodegradable layers |
US20100228348A1 (en) * | 2007-05-25 | 2010-09-09 | Micell Technologies, Inc. | Polymer Films for Medical Device Coating |
US20100239635A1 (en) * | 2009-03-23 | 2010-09-23 | Micell Technologies, Inc. | Drug delivery medical device |
US20100241220A1 (en) * | 2009-03-23 | 2010-09-23 | Mcclain James B | Peripheral Stents Having Layers |
US20100256746A1 (en) * | 2009-03-23 | 2010-10-07 | Micell Technologies, Inc. | Biodegradable polymers |
US20100256748A1 (en) * | 2009-04-01 | 2010-10-07 | Micell Technologies, Inc. | Coated stents |
US20100272778A1 (en) * | 2007-04-17 | 2010-10-28 | Micell Technologies, Inc. | Stents having controlled elution |
US20100298928A1 (en) * | 2007-10-19 | 2010-11-25 | Micell Technologies, Inc. | Drug Coated Stents |
US20110159069A1 (en) * | 2008-12-26 | 2011-06-30 | Shaw Wendy J | Medical Implants and Methods of Making Medical Implants |
US20110190864A1 (en) * | 2010-02-02 | 2011-08-04 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US20110238161A1 (en) * | 2010-03-26 | 2011-09-29 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
WO2011130448A1 (fr) * | 2010-04-16 | 2011-10-20 | Micell Technologies, Inc. | Endoprothèses vasculaires ayant une élution contrôlée |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
US9636309B2 (en) | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
US10117972B2 (en) | 2011-07-15 | 2018-11-06 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
US10272606B2 (en) | 2013-05-15 | 2019-04-30 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US10835396B2 (en) | 2005-07-15 | 2020-11-17 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US11039943B2 (en) | 2013-03-12 | 2021-06-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
US11904118B2 (en) | 2010-07-16 | 2024-02-20 | Micell Medtech Inc. | Drug delivery medical device |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1400977B1 (it) | 2010-07-01 | 2013-07-05 | Euticals Spa | Nuovi complessi di inclusione farmaceutici, solidi, solubili in acqua e le loro soluzioni acquose per uso orale, oftalmico, topico o parenterale, contenenti un macrolide ed alcune ciclodestrine. |
US11406742B2 (en) | 2014-07-18 | 2022-08-09 | M.A. Med Alliance SA | Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs |
CN104525944A (zh) * | 2014-12-23 | 2015-04-22 | 北京理工大学 | 一种金属材料高能束-超声复合增材制造方法 |
KR102601927B1 (ko) * | 2017-01-05 | 2023-11-15 | 삼성전자주식회사 | 커버 및 이를 포함하는 전자 장치 |
US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
CN111450064A (zh) * | 2020-04-09 | 2020-07-28 | 广州中医药大学(广州中医药研究院) | 基于超临界反溶剂法制备西罗莫司包覆颗粒的方法及其制得的西罗莫司包覆颗粒和应用 |
Citations (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3087860A (en) * | 1958-12-19 | 1963-04-30 | Abbott Lab | Method of prolonging release of drug from a precompressed solid carrier |
US3087660A (en) * | 1962-07-24 | 1963-04-30 | Yankee Plasties Inc | Two-step garment hanger |
US4326532A (en) * | 1980-10-06 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Antithrombogenic articles |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5158986A (en) * | 1991-04-05 | 1992-10-27 | Massachusetts Institute Of Technology | Microcellular thermoplastic foamed with supercritical fluid |
US5243023A (en) * | 1991-08-28 | 1993-09-07 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Polyimides containing amide and perfluoroisopropylidene connecting groups |
US5340614A (en) * | 1993-02-11 | 1994-08-23 | Minnesota Mining And Manufacturing Company | Methods of polymer impregnation |
US5342621A (en) * | 1992-09-15 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Antithrombogenic surface |
US5356433A (en) * | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
US5569463A (en) * | 1990-05-17 | 1996-10-29 | Harbor Medical Devices, Inc. | Medical device polymer |
US5811032A (en) * | 1995-09-19 | 1998-09-22 | Mitsubishi Gas Chemical Company, Inc. | Biodegradable water-soluble polymer |
US5824049A (en) * | 1995-06-07 | 1998-10-20 | Med Institute, Inc. | Coated implantable medical device |
US5948020A (en) * | 1995-05-01 | 1999-09-07 | Sam Yang Co., Ltd. | Implantable bioresorbable membrane and method for the preparation thereof |
US5957975A (en) * | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
US6190699B1 (en) * | 1998-05-08 | 2001-02-20 | Nzl Corporation | Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6364903B2 (en) * | 1999-03-19 | 2002-04-02 | Meadox Medicals, Inc. | Polymer coated stent |
US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US6372246B1 (en) * | 1998-12-16 | 2002-04-16 | Ortho-Mcneil Pharmaceutical, Inc. | Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals |
US6409716B1 (en) * | 1989-12-15 | 2002-06-25 | Scimed Life Systems, Inc. | Drug delivery |
US6414050B1 (en) * | 1997-05-10 | 2002-07-02 | University Of Nottingham | Biofunctional polymers prepared in supercritical fluid |
US20020091433A1 (en) * | 1995-04-19 | 2002-07-11 | Ni Ding | Drug release coated stent |
US6448315B1 (en) * | 1999-02-17 | 2002-09-10 | Bone Support Ab | Method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof |
US20020133072A1 (en) * | 1999-09-10 | 2002-09-19 | Guo-Bin Wang | Graft polymerization of substrate surfaces |
US6461644B1 (en) * | 1996-03-25 | 2002-10-08 | Richard R. Jackson | Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods |
US6506213B1 (en) * | 2000-09-08 | 2003-01-14 | Ferro Corporation | Manufacturing orthopedic parts using supercritical fluid processing techniques |
US6517860B1 (en) * | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
US20030031699A1 (en) * | 2002-09-30 | 2003-02-13 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
US6521258B1 (en) * | 2000-09-08 | 2003-02-18 | Ferro Corporation | Polymer matrices prepared by supercritical fluid processing techniques |
US6524698B1 (en) * | 1990-09-27 | 2003-02-25 | Helmuth Schmoock | Fluid impermeable foil |
US20030088307A1 (en) * | 2001-11-05 | 2003-05-08 | Shulze John E. | Potent coatings for stents |
US20030125800A1 (en) * | 2001-11-05 | 2003-07-03 | Shulze John E. | Drug-delivery endovascular stent and method for treating restenosis |
US20030143315A1 (en) * | 2001-05-16 | 2003-07-31 | Pui David Y H | Coating medical devices |
US20030180376A1 (en) * | 2001-03-02 | 2003-09-25 | Dalal Paresh S. | Porous beta-tricalcium phosphate granules and methods for producing same |
US6627246B2 (en) * | 2000-05-16 | 2003-09-30 | Ortho-Mcneil Pharmaceutical, Inc. | Process for coating stents and other medical devices using super-critical carbon dioxide |
US20030185964A1 (en) * | 2002-03-28 | 2003-10-02 | Jan Weber | Method for spray-coating a medical device having a tubular wall such as a stent |
US20030204238A1 (en) * | 2002-04-26 | 2003-10-30 | Eugene Tedeschi | Coated stent with crimpable coating |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
US6710059B1 (en) * | 1999-07-06 | 2004-03-23 | Endorecherche, Inc. | Methods of treating and/or suppressing weight gain |
US6720003B2 (en) * | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
US6736996B1 (en) * | 1997-10-10 | 2004-05-18 | North Carolina State University | Compositions for protecting civil infrastructure |
US20040106982A1 (en) * | 1999-03-16 | 2004-06-03 | Jalisi Marc M. | Multilayer stent |
US6749902B2 (en) * | 2002-05-28 | 2004-06-15 | Battelle Memorial Institute | Methods for producing films using supercritical fluid |
US6756084B2 (en) * | 2002-05-28 | 2004-06-29 | Battelle Memorial Institute | Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions |
US6755871B2 (en) * | 1999-10-15 | 2004-06-29 | R.R. Street & Co. Inc. | Cleaning system utilizing an organic cleaning solvent and a pressurized fluid solvent |
US20040126542A1 (en) * | 2002-07-29 | 2004-07-01 | Nitto Denko Corporation | Pressure-sensitive adhesive tape or sheet |
US6767558B2 (en) * | 2000-03-10 | 2004-07-27 | Pfizer Inc. | Inhibiting oxidative degradation of pharmaceutical formulations |
US6780475B2 (en) * | 2002-05-28 | 2004-08-24 | Battelle Memorial Institute | Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions |
US20040193177A1 (en) * | 2003-03-31 | 2004-09-30 | Houghton Michael J. | Modified delivery device for coated medical devices |
US20040193262A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US6837611B2 (en) * | 2001-12-28 | 2005-01-04 | Metal Industries Research & Development Centre | Fluid driven agitator used in densified gas cleaning system |
US6838528B2 (en) * | 2001-01-19 | 2005-01-04 | Nektar Therapeutics Al, Corporation | Multi-arm block copolymers as drug delivery vehicles |
US6838089B1 (en) * | 1998-04-14 | 2005-01-04 | Astrazeneca Ab | Antigen delivery system and method of production |
US20050003074A1 (en) * | 1996-11-13 | 2005-01-06 | Phoqus Pharmaceuticals Limited | Method and apparatus for the coating of substrates for pharmaceutical use |
US20050004661A1 (en) * | 2001-01-11 | 2005-01-06 | Lewis Andrew L | Stens with drug-containing amphiphilic polymer coating |
US20050010275A1 (en) * | 2002-10-11 | 2005-01-13 | Sahatjian Ronald A. | Implantable medical devices |
US20050015046A1 (en) * | 2003-07-18 | 2005-01-20 | Scimed Life Systems, Inc. | Medical devices and processes for preparing same |
US20050019747A1 (en) * | 2002-08-07 | 2005-01-27 | Anderson Daniel G. | Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
US20050049694A1 (en) * | 2003-08-07 | 2005-03-03 | Medtronic Ave. | Extrusion process for coating stents |
US6868123B2 (en) * | 2001-12-07 | 2005-03-15 | Motorola, Inc. | Programmable motion estimation module with vector array unit |
US20050069630A1 (en) * | 2003-09-30 | 2005-03-31 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US20050079274A1 (en) * | 2003-10-14 | 2005-04-14 | Maria Palasis | Method for coating multiple stents |
US6884823B1 (en) * | 1997-01-16 | 2005-04-26 | Trexel, Inc. | Injection molding of polymeric material |
US6884377B1 (en) * | 1996-08-27 | 2005-04-26 | Trexel, Inc. | Method and apparatus for microcellular polymer extrusion |
US6897205B2 (en) * | 2001-01-31 | 2005-05-24 | Roehm Gmbh & Co. Kg | Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
US6905555B2 (en) * | 2001-02-15 | 2005-06-14 | Micell Technologies, Inc. | Methods for transferring supercritical fluids in microelectronic and other industrial processes |
US20050147734A1 (en) * | 2004-01-07 | 2005-07-07 | Jan Seppala | Method and system for coating tubular medical devices |
US20050177223A1 (en) * | 2003-09-18 | 2005-08-11 | Palmaz Julio C. | Medical devices having MEMs functionality and methods of making same |
US20050175772A1 (en) * | 2004-02-10 | 2005-08-11 | Robert Worsham | Apparatus and method for electrostatic spray coating of medical devices |
US20050191491A1 (en) * | 2003-04-08 | 2005-09-01 | Yulu Wang | Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process |
US6939569B1 (en) * | 1998-06-19 | 2005-09-06 | Oxibio, Inc. | Medical device having anti-infective and contraceptive properties |
US20050196424A1 (en) * | 2003-05-02 | 2005-09-08 | Chappa Ralph A. | Medical devices and methods for producing the same |
US20050216075A1 (en) * | 2003-04-08 | 2005-09-29 | Xingwu Wang | Materials and devices of enhanced electromagnetic transparency |
US20050238829A1 (en) * | 2004-04-22 | 2005-10-27 | John Motherwell | Differentially coated medical devices, system for differentially coating medical devices, and coating method |
US20060020325A1 (en) * | 2004-07-26 | 2006-01-26 | Robert Burgermeister | Material for high strength, controlled recoil stent |
US20060094744A1 (en) * | 2004-09-29 | 2006-05-04 | Maryanoff Cynthia A | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
US20060121089A1 (en) * | 2002-03-20 | 2006-06-08 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices |
US20060134211A1 (en) * | 2004-12-16 | 2006-06-22 | Miv Therapeutics Inc. | Multi-layer drug delivery device and method of manufacturing same |
US20060136041A1 (en) * | 2004-12-17 | 2006-06-22 | Schmid Eric V | Slide-and-lock stent |
US20060193886A1 (en) * | 2002-11-13 | 2006-08-31 | Owens Gary K | Medical devices with nanoporous layers and topcoats |
US20060198868A1 (en) * | 2005-01-05 | 2006-09-07 | Dewitt David M | Biodegradable coating compositions comprising blends |
US20060222756A1 (en) * | 2000-09-29 | 2006-10-05 | Cordis Corporation | Medical devices, drug coatings and methods of maintaining the drug coatings thereon |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US7163715B1 (en) * | 2001-06-12 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Spray processing of porous medical devices |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
US20070123977A1 (en) * | 2000-03-15 | 2007-05-31 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
US20070196423A1 (en) * | 2005-11-21 | 2007-08-23 | Med Institute, Inc. | Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent |
US20070203569A1 (en) * | 2006-02-24 | 2007-08-30 | Robert Burgermeister | Implantable device formed from polymer blends having modified molecular structures |
US7279174B2 (en) * | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
US20080075753A1 (en) * | 2006-09-25 | 2008-03-27 | Chappa Ralph A | Multi-layered coatings and methods for controlling elution of active agents |
US7378105B2 (en) * | 1997-09-26 | 2008-05-27 | Abbott Laboratories | Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens |
US20080206304A1 (en) * | 2007-02-27 | 2008-08-28 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions based on styrene-isobutylene copolymers |
US20080213464A1 (en) * | 2007-01-03 | 2008-09-04 | Boston Scientific Scimed, Inc. | Methods of applying coating to the inside surface of a stent |
US20080255510A1 (en) * | 2006-11-20 | 2008-10-16 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US20090105809A1 (en) * | 2007-10-19 | 2009-04-23 | Lee Michael J | Implantable and lumen-supporting stents and related methods of manufacture and use |
Family Cites Families (507)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123077A (en) | 1964-03-03 | Surgical suture | ||
US3457280A (en) | 1967-06-12 | 1969-07-22 | American Cyanamid Co | Alpha-glycolide and methods for the isolation thereof |
US3597449A (en) | 1967-11-16 | 1971-08-03 | American Cyanamid Co | Stable glycolide and lactide composition |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
DE2010115A1 (de) | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US4000137A (en) | 1975-06-10 | 1976-12-28 | American Home Products Corporation | Antitumor derivatives of periodate-oxidized nucleosides |
US4188373A (en) | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4285987A (en) | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
JPS5668674A (en) | 1979-11-08 | 1981-06-09 | Shionogi & Co Ltd | 5-fluorouracil derivative |
US4389330A (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
US4474572A (en) | 1981-09-29 | 1984-10-02 | Syntex (U.S.A.) Inc. | Implanting device and implant magazine |
SE445884B (sv) | 1982-04-30 | 1986-07-28 | Medinvent Sa | Anordning for implantation av en rorformig protes |
US4530840A (en) | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
SE435444B (sv) | 1983-02-25 | 1984-10-01 | Hakan Johansson | Fiskeredskap med en fangstlina som utgores av en ljusledare |
US4606347A (en) | 1983-03-25 | 1986-08-19 | Thomas J. Fogarty | Inverted balloon catheter having sealed through lumen |
US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
US4478822A (en) | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4582731A (en) | 1983-09-01 | 1986-04-15 | Battelle Memorial Institute | Supercritical fluid molecular spray film deposition and powder formation |
US4734227A (en) | 1983-09-01 | 1988-03-29 | Battelle Memorial Institute | Method of making supercritical fluid molecular spray films, powder and fibers |
US4734451A (en) | 1983-09-01 | 1988-03-29 | Battelle Memorial Institute | Supercritical fluid molecular spray thin films and fine powders |
US6309669B1 (en) | 1984-03-16 | 2001-10-30 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4985625A (en) | 1986-03-06 | 1991-01-15 | Finnigan Corporation | Transfer line for mass spectrometer apparatus |
US4762593A (en) | 1986-06-13 | 1988-08-09 | Youngner Philip G | Distilling apparatus |
US4758435A (en) | 1986-08-11 | 1988-07-19 | American Cyanamid Company | Estradiol implant composition and method for preparation |
JPH068902Y2 (ja) | 1988-04-19 | 1994-03-09 | マツダ株式会社 | 車両用始動安全装置 |
US5106650A (en) | 1988-07-14 | 1992-04-21 | Union Carbide Chemicals & Plastics Technology Corporation | Electrostatic liquid spray application of coating with supercritical fluids as diluents and spraying from an orifice |
US4950239A (en) | 1988-08-09 | 1990-08-21 | Worldwide Medical Plastics Inc. | Angioplasty balloons and balloon catheters |
ATE121954T1 (de) | 1988-08-24 | 1995-05-15 | Marvin J Slepian | Endoluminale dichtung mit bisdegradierbaren polymeren. |
US4931037A (en) | 1988-10-13 | 1990-06-05 | International Medical, Inc. | In-dwelling ureteral stent and injection stent assembly, and method of using same |
US4958625A (en) | 1989-07-18 | 1990-09-25 | Boston Scientific Corporation | Biopsy needle instrument |
DE69002295T2 (de) | 1989-09-25 | 1993-11-04 | Schneider Usa Inc | Mehrschichtextrusion als verfahren zur herstellung von ballons zur gefaessplastik. |
CA2026604A1 (fr) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Drain articule |
US5000519A (en) | 1989-11-24 | 1991-03-19 | John Moore | Towed vehicle emergency brake control system |
JP2641781B2 (ja) | 1990-02-23 | 1997-08-20 | シャープ株式会社 | 半導体素子分離領域の形成方法 |
US5545208A (en) | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5360403A (en) | 1990-05-16 | 1994-11-01 | Lake Region Manufacturing Co., Inc. | Balloon catheter with lumen occluder |
US5320634A (en) | 1990-07-03 | 1994-06-14 | Interventional Technologies, Inc. | Balloon catheter with seated cutting edges |
US5090419A (en) | 1990-08-23 | 1992-02-25 | Aubrey Palestrant | Apparatus for acquiring soft tissue biopsy specimens |
US6248129B1 (en) | 1990-09-14 | 2001-06-19 | Quanam Medical Corporation | Expandable polymeric stent with memory and delivery apparatus and method |
CA2060635A1 (fr) | 1991-02-12 | 1992-08-13 | Keith D'alessio | Implants medicaux bioabsorbables |
GB2253164B (en) | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
US5195969A (en) | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
US5372676A (en) | 1991-05-15 | 1994-12-13 | Lowe; Michael | Method for producing replicated paving stone |
US5185776A (en) | 1991-08-05 | 1993-02-09 | Townsend Boyd E | Cover for an x-ray cassette |
US5366504A (en) | 1992-05-20 | 1994-11-22 | Boston Scientific Corporation | Tubular medical prosthesis |
US5125570A (en) | 1991-12-30 | 1992-06-30 | Robert Jones | Delivery box signal device |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5876452A (en) | 1992-02-14 | 1999-03-02 | Board Of Regents, University Of Texas System | Biodegradable implant |
JPH07505316A (ja) | 1992-03-31 | 1995-06-15 | ボストン サイエンティフィック コーポレーション | 医療用ワイヤ |
US5288711A (en) | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5500180A (en) | 1992-09-30 | 1996-03-19 | C. R. Bard, Inc. | Method of making a distensible dilatation balloon using a block copolymer |
GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5387313A (en) | 1992-11-09 | 1995-02-07 | Bmc Industries, Inc. | Etchant control system |
US5385776A (en) | 1992-11-16 | 1995-01-31 | Alliedsignal Inc. | Nanocomposites of gamma phase polymers containing inorganic particulate material |
EP0604022A1 (fr) | 1992-12-22 | 1994-06-29 | Advanced Cardiovascular Systems, Inc. | Endoprothèse résorbable, à plusieurs couches, pour le maintien des vaisseaux, et sa méthode de fabrication |
US5324049A (en) | 1992-12-23 | 1994-06-28 | Xerox Corporation | Mandrel with flared, dish shaped disk and process for using mandrel |
BR9307814A (pt) | 1993-01-19 | 1995-11-14 | Schneider Usa Inc | Dispositivo protético compósito blindado |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6228879B1 (en) | 1997-10-16 | 2001-05-08 | The Children's Medical Center | Methods and compositions for inhibition of angiogenesis |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
CA2157793C (fr) | 1993-03-09 | 1999-07-13 | James E. Woiszwillo | Microparticules macromoleculaires et methode de production |
JPH08507715A (ja) | 1993-03-18 | 1996-08-20 | シーダーズ サイナイ メディカル センター | 生体人工部材のための薬剤導入性および放出性重合性コーティング |
US20020055710A1 (en) | 1998-04-30 | 2002-05-09 | Ronald J. Tuch | Medical device for delivering a therapeutic agent and method of preparation |
US5403347A (en) | 1993-05-27 | 1995-04-04 | United States Surgical Corporation | Absorbable block copolymers and surgical articles fabricated therefrom |
US5350627A (en) | 1993-06-11 | 1994-09-27 | Camelot Technologies, Inc. | Coated webs |
US5380299A (en) | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
DE4336209C2 (de) | 1993-09-10 | 1995-09-21 | Michael Dr Simon | Verfahren zur Herstellung einer mit antithrombotischen Agenzien beschichteten Gefäßprothese |
US5632772A (en) | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5350361A (en) | 1993-11-10 | 1994-09-27 | Medtronic, Inc. | Tri-fold balloon for dilatation catheter and related method |
US5494620A (en) | 1993-11-24 | 1996-02-27 | United States Surgical Corporation | Method of manufacturing a monofilament suture |
US5626611A (en) | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
US6146356A (en) | 1994-03-02 | 2000-11-14 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
DE69514910T3 (de) | 1994-03-02 | 2009-09-24 | Boston Scientific Ltd., Hastings Christ Church | Blockcopolymerelastomer ballon für katheter |
US5733303A (en) | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
JPH10503179A (ja) | 1994-06-24 | 1998-03-24 | イミュネックス・コーポレーション | 放出制御性ポリペプチド組成物および炎症性腸疾患の治療方法 |
JP3672314B2 (ja) | 1994-07-12 | 2005-07-20 | バーウィンド・ファーマスーティカル・サーヴィスィーズ・インコーポレーテッド | 防湿性フィルム被覆材組成物、方法および被覆成形物 |
US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
NL9401690A (nl) | 1994-10-13 | 1996-05-01 | Industrial Res Bv | In een lichaamsvat implanteerbare stent. |
CA2206734A1 (fr) | 1994-12-02 | 1996-06-06 | Science Incorporated | Doseur de medicaments |
WO1996020698A2 (fr) | 1995-01-05 | 1996-07-11 | The Board Of Regents Acting For And On Behalf Of The University Of Michigan | Nanoparticules a modification de surface et leurs procedes de fabrication et d'utilisation |
US5599576A (en) | 1995-02-06 | 1997-02-04 | Surface Solutions Laboratories, Inc. | Medical apparatus with scratch-resistant coating and method of making same |
US6231600B1 (en) | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
US5605696A (en) | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
WO1996032907A1 (fr) | 1995-04-19 | 1996-10-24 | Schneider (Usa) Inc. | Extenseur avec un revetement capable de liberer un medicament |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US5570537A (en) | 1995-04-27 | 1996-11-05 | Black; Douglas A. | Electronic insecticidal cable |
US6602281B1 (en) | 1995-06-05 | 2003-08-05 | Avantec Vascular Corporation | Radially expansible vessel scaffold having beams and expansion joints |
US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
US5674242A (en) | 1995-06-06 | 1997-10-07 | Quanam Medical Corporation | Endoprosthetic device with therapeutic compound |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
CA2219659C (fr) | 1995-06-09 | 2008-03-18 | Novartis Ag | Derives de rapamycine |
US6256529B1 (en) | 1995-07-26 | 2001-07-03 | Burdette Medical Systems, Inc. | Virtual reality 3D visualization for surgical procedures |
JP3476604B2 (ja) | 1995-08-22 | 2003-12-10 | 鐘淵化学工業株式会社 | 薬剤を付着・コーティングしたステントの製造方法 |
US5607442A (en) | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
CA2192520A1 (fr) | 1996-03-05 | 1997-09-05 | Ian M. Penn | Tringle extensible et methode de mise en place de ladite tringle |
NZ331269A (en) | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
US5669932A (en) | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
DK0903389T3 (da) | 1996-05-31 | 2010-01-18 | Toto Ltd | Antifouling-element og antifouling-coating-sammensætning |
US6143037A (en) | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
US5876426A (en) | 1996-06-13 | 1999-03-02 | Scimed Life Systems, Inc. | System and method of providing a blood-free interface for intravascular light delivery |
FR2750897B1 (fr) | 1996-07-10 | 1998-09-18 | Sames Sa | Projecteur triboelectrique, installation de projection de produit de revetement et procede de commande d'un tel projecteur |
US6258823B1 (en) | 1996-07-12 | 2001-07-10 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
JPH1029524A (ja) | 1996-07-15 | 1998-02-03 | Toyota Motor Corp | 車輪スリップ制御装置 |
US5871436A (en) | 1996-07-19 | 1999-02-16 | Advanced Cardiovascular Systems, Inc. | Radiation therapy method and device |
EP0820784B1 (fr) | 1996-07-24 | 2003-06-11 | Cordis Corporation | Cathéter à ballon et méthode de son emploie |
US6013855A (en) | 1996-08-06 | 2000-01-11 | United States Surgical | Grafting of biocompatible hydrophilic polymers onto inorganic and metal surfaces |
DE19633901A1 (de) | 1996-08-22 | 1998-02-26 | Thomas Prof Dr Med Ischinger | Gefäßstütze in Form einer Schlauchabschnitts-artigen Stützstruktur |
US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6193963B1 (en) | 1996-10-17 | 2001-02-27 | The Regents Of The University Of California | Method of treating tumor-bearing patients with human plasma hyaluronidase |
US6387121B1 (en) | 1996-10-21 | 2002-05-14 | Inflow Dynamics Inc. | Vascular and endoluminal stents with improved coatings |
US6530951B1 (en) | 1996-10-24 | 2003-03-11 | Cook Incorporated | Silver implantable medical device |
US6251980B1 (en) | 1996-12-06 | 2001-06-26 | Amcol International Corporation | Nanocomposites formed by onium ion-intercalated clay and rigid anhydride-cured epoxy resins |
US5871437A (en) | 1996-12-10 | 1999-02-16 | Inflow Dynamics, Inc. | Radioactive stent for treating blood vessels to prevent restenosis |
FR2758253B1 (fr) | 1997-01-10 | 1999-04-02 | Nycomed Lab Sa | Dispositif implantable pour le traitement d'un conduit corporel |
DE29702671U1 (de) | 1997-02-17 | 1997-04-10 | Jomed Implantate GmbH, 72414 Rangendingen | Stent |
ES2388248T3 (es) | 1997-03-31 | 2012-10-11 | Boston Scientific Scimed Limited | Forma de dosificación que comprende taxol en forma cristalina |
US8172897B2 (en) | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
IT1292295B1 (it) | 1997-04-29 | 1999-01-29 | Sorin Biomedica Cardio Spa | Stent per angioplastica |
FR2762777B1 (fr) | 1997-05-05 | 1999-10-22 | Patrick Sabaria | Extenseurs vasculaires et coronaires, habituellement designes sous le nom de "stent" |
WO1998051238A1 (fr) | 1997-05-14 | 1998-11-19 | Novo Rps Ulc | Prothese endovasculaire extensible et son procede de production |
DE19720115C2 (de) | 1997-05-14 | 1999-05-20 | Jomed Implantate Gmbh | Stent-Graft |
DE29708689U1 (de) | 1997-05-15 | 1997-07-17 | Jomed Implantate GmbH, 72414 Rangendingen | Koronarer Stent |
US5913895A (en) | 1997-06-02 | 1999-06-22 | Isostent, Inc. | Intravascular stent with enhanced rigidity strut members |
US6416779B1 (en) | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
US6433154B1 (en) | 1997-06-12 | 2002-08-13 | Bristol-Myers Squibb Company | Functional receptor/kinase chimera in yeast cells |
US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US6077880A (en) | 1997-08-08 | 2000-06-20 | Cordis Corporation | Highly radiopaque polyolefins and method for making the same |
AU8782098A (en) | 1997-08-13 | 1999-03-08 | Boston Scientific Limited | Loading and release of water-insoluble drugs |
DE69832089T2 (de) | 1997-08-28 | 2006-07-20 | Nissan Chemical Industries, Ltd. | Mittel zur förderung und verstärkung der neovaskularisierung |
DE29716476U1 (de) | 1997-09-13 | 1997-12-18 | Convent, Gerd, 47829 Krefeld | Stent zur Stenosebehandlung |
DE29716467U1 (de) | 1997-09-15 | 1998-02-26 | Rittal-Werk Rudolf Loh Gmbh & Co Kg, 35745 Herborn | Gehäuseaufbau für elektrische oder elektronische Einbauten |
TW557297B (en) | 1997-09-26 | 2003-10-11 | Abbott Lab | Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same |
US8257725B2 (en) | 1997-09-26 | 2012-09-04 | Abbott Laboratories | Delivery of highly lipophilic agents via medical devices |
US6042606A (en) | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US6071308A (en) | 1997-10-01 | 2000-06-06 | Boston Scientific Corporation | Flexible metal wire stent |
IE980920A1 (en) | 1997-11-07 | 1999-05-19 | Salviac Ltd | An embolic protection device |
US6635269B1 (en) | 1997-11-24 | 2003-10-21 | Morphoplant Gmbh | Immobilizing mediator molecules via anchor molecules on metallic implant materials containing oxide layer |
JP2002500065A (ja) | 1998-01-06 | 2002-01-08 | バイオアミド・インコーポレイテッド | 生体吸収性繊維およびそれから製造される強化コンポジット |
US6129755A (en) | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
ATE326919T1 (de) | 1998-03-04 | 2006-06-15 | Boston Scient Ltd | Stent mit verbesserter zellenkonfiguration |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US8029561B1 (en) | 2000-05-12 | 2011-10-04 | Cordis Corporation | Drug combination useful for prevention of restenosis |
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
US6206914B1 (en) | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
DE19822157B4 (de) | 1998-05-16 | 2013-01-10 | Abbott Laboratories Vascular Enterprises Ltd. | Radial aufweitbarer Stent zur Implantierung in ein Körpergefäß |
FR2780057B1 (fr) | 1998-06-18 | 2002-09-13 | Sanofi Sa | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant |
US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
US7967855B2 (en) | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
US7004962B2 (en) | 1998-07-27 | 2006-02-28 | Schneider (Usa), Inc. | Neuroaneurysm occlusion and delivery device and method of using same |
US8070796B2 (en) | 1998-07-27 | 2011-12-06 | Icon Interventional Systems, Inc. | Thrombosis inhibiting graft |
US6461380B1 (en) | 1998-07-28 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Stent configuration |
US6248127B1 (en) | 1998-08-21 | 2001-06-19 | Medtronic Ave, Inc. | Thromboresistant coated medical device |
US6193744B1 (en) | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US6342062B1 (en) | 1998-09-24 | 2002-01-29 | Scimed Life Systems, Inc. | Retrieval devices for vena cava filter |
US6363104B1 (en) | 1998-10-02 | 2002-03-26 | Ericsson Inc. | Method and apparatus for interference cancellation in a rake receiver |
US6245104B1 (en) | 1999-02-28 | 2001-06-12 | Inflow Dynamics Inc. | Method of fabricating a biocompatible stent |
US6042597A (en) | 1998-10-23 | 2000-03-28 | Scimed Life Systems, Inc. | Helical stent design |
US6143314A (en) | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
FR2785174A1 (fr) | 1998-11-03 | 2000-05-05 | Jacques Seguin | Extenseur de conduit corporel, notamment vasculaire |
US6355691B1 (en) | 1998-11-12 | 2002-03-12 | Tobias M. Goodman | Urushiol therapy of transitional cell carcinoma of the bladder |
US6497729B1 (en) | 1998-11-20 | 2002-12-24 | The University Of Connecticut | Implant coating for control of tissue/implant interactions |
CA2353606A1 (fr) | 1998-12-03 | 2000-06-08 | Boston Scientific Limited | Endoprothese comportant en surface un principe actif sous forme de cristaux |
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6147135A (en) | 1998-12-31 | 2000-11-14 | Ethicon, Inc. | Fabrication of biocompatible polymeric composites |
US6638727B1 (en) | 1999-01-26 | 2003-10-28 | Cytyc Health Corporation | Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
US6171327B1 (en) | 1999-02-24 | 2001-01-09 | Scimed Life Systems, Inc. | Intravascular filter and method |
SE9901002D0 (sv) | 1999-03-19 | 1999-03-19 | Electrolux Ab | Anordning för rengöring av textilföremål med en förtätad vätskeformig behandlingsgas |
US6923979B2 (en) | 1999-04-27 | 2005-08-02 | Microdose Technologies, Inc. | Method for depositing particles onto a substrate using an alternating electric field |
US8016873B1 (en) | 1999-05-03 | 2011-09-13 | Drasler William J | Intravascular hinge stent |
US6726712B1 (en) | 1999-05-14 | 2004-04-27 | Boston Scientific Scimed | Prosthesis deployment device with translucent distal end |
JP2000316981A (ja) | 1999-05-14 | 2000-11-21 | Kawasumi Lab Inc | ステント |
US6815218B1 (en) | 1999-06-09 | 2004-11-09 | Massachusetts Institute Of Technology | Methods for manufacturing bioelectronic devices |
AU783158B2 (en) | 1999-08-24 | 2005-09-29 | Ariad Pharmaceuticals, Inc. | 28-epirapalogs |
US6146404A (en) | 1999-09-03 | 2000-11-14 | Scimed Life Systems, Inc. | Removable thrombus filter |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US6610013B1 (en) | 1999-10-01 | 2003-08-26 | Life Imaging Systems, Inc. | 3D ultrasound-guided intraoperative prostate brachytherapy |
US6458387B1 (en) | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
US7537785B2 (en) | 1999-10-29 | 2009-05-26 | Nitromed, Inc. | Composition for treating vascular diseases characterized by nitric oxide insufficiency |
US6537310B1 (en) | 1999-11-19 | 2003-03-25 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal implantable devices and method of making same |
US6908624B2 (en) | 1999-12-23 | 2005-06-21 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6572813B1 (en) | 2000-01-13 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Balloon forming process |
TWI284048B (en) | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
EP1132058A1 (fr) | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Prothèse intravasculaire |
CN2423899Y (zh) | 2000-05-08 | 2001-03-21 | 微创医疗器械(上海)有限公司 | 冠状动脉支架 |
AU6145501A (en) | 2000-05-12 | 2001-11-26 | Advanced Bio Prosthetic Surfac | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same |
US7217770B2 (en) | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
US20020144757A1 (en) | 2000-07-07 | 2002-10-10 | Craig Charles Horace | Stainless steel alloy with improved radiopaque characteristics |
US20030077200A1 (en) | 2000-07-07 | 2003-04-24 | Craig Charles H. | Enhanced radiopaque alloy stent |
CN102871979B (zh) | 2000-09-01 | 2014-10-22 | 帕尔马亚有限公司 | 缓释药物制剂及其施用方法 |
US7332242B2 (en) | 2000-09-01 | 2008-02-19 | Itochu Corporation | Lithium-based battery having extensible, ion-impermeable polymer covering on the battery container |
US6362718B1 (en) | 2000-09-06 | 2002-03-26 | Stephen L. Patrick | Motionless electromagnetic generator |
US6953560B1 (en) | 2000-09-28 | 2005-10-11 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
US20020111590A1 (en) | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
WO2002026281A1 (fr) | 2000-09-29 | 2002-04-04 | Cordis Corporation | Dispositifs medicaux avec enrobages |
JP2004537495A (ja) | 2000-11-03 | 2004-12-16 | コントロール・デリバリー・システムズ | 関節疾患を治療するための改善された装置及び方法 |
US20040018228A1 (en) | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
US20050084514A1 (en) | 2000-11-06 | 2005-04-21 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
AU2002239491A1 (en) | 2000-11-09 | 2002-05-27 | Vanderbilt University | Methods for the treatment of cancer and other diseases and methods of developing the same |
US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
KR20020076265A (ko) | 2000-11-30 | 2002-10-09 | 가부시키가이샤 이가키 이료 세케이 | 혈관용 스텐트 및 혈관용 스텐트용 소재 |
US6913617B1 (en) | 2000-12-27 | 2005-07-05 | Advanced Cardiovascular Systems, Inc. | Method for creating a textured surface on an implantable medical device |
GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
WO2002059184A2 (fr) | 2001-01-24 | 2002-08-01 | Virginia Commonwealth University | Impression moleculaire de petites particules et production de petites particules a partir de reactifs solides |
US20040220660A1 (en) | 2001-02-05 | 2004-11-04 | Shanley John F. | Bioresorbable stent with beneficial agent reservoirs |
DE10106810A1 (de) | 2001-02-14 | 2002-09-05 | Siemens Ag | Netzunabhängige Stromversorgungseinheit |
US6811549B2 (en) | 2001-02-16 | 2004-11-02 | William H. Fleming | Administration of therapeutic or diagnostic agents using interlabial pad |
JP2002239013A (ja) | 2001-02-21 | 2002-08-27 | Terumo Corp | ステント及びその製造方法 |
WO2002074194A2 (fr) | 2001-03-16 | 2002-09-26 | Sts Biopolymers, Inc. | Revetement polymere multicouche medicamenteux |
US7771468B2 (en) | 2001-03-16 | 2010-08-10 | Angiotech Biocoatings Corp. | Medicated stent having multi-layer polymer coating |
WO2002085188A2 (fr) | 2001-04-24 | 2002-10-31 | Kaplan Edward J | Dispositif d'implantation flexible et son procede d'utilisation |
US20040022853A1 (en) | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
WO2002096389A1 (fr) | 2001-05-30 | 2002-12-05 | Microchips, Inc. | Dispositifs reservoirs a micropuce pourvus d'un revetement conforme |
US20030044514A1 (en) | 2001-06-13 | 2003-03-06 | Richard Robert E. | Using supercritical fluids to infuse therapeutic on a medical device |
US7485113B2 (en) | 2001-06-22 | 2009-02-03 | Johns Hopkins University | Method for drug delivery through the vitreous humor |
US7501157B2 (en) | 2001-06-26 | 2009-03-10 | Accelr8 Technology Corporation | Hydroxyl functional surface coating |
US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
US6967234B2 (en) | 2002-12-18 | 2005-11-22 | Ethicon, Inc. | Alkyd-lactone copolymers for medical applications |
US7015875B2 (en) | 2001-06-29 | 2006-03-21 | Novus Partners Llc | Dynamic device for billboard advertising |
US6743505B2 (en) | 2001-07-27 | 2004-06-01 | Ethicon, Inc. | Bioabsorbable multifilament yarn and methods of manufacture |
US6723913B1 (en) | 2001-08-23 | 2004-04-20 | Anthony T. Barbetta | Fan cooling of active speakers |
US6669980B2 (en) | 2001-09-18 | 2003-12-30 | Scimed Life Systems, Inc. | Method for spray-coating medical devices |
CN1568166A (zh) | 2001-10-15 | 2005-01-19 | 荷姆泰克股份有限公司 | 预防再狭窄的涂层支架 |
EP1441707A1 (fr) | 2001-11-09 | 2004-08-04 | Pharmacia AB | Agent anti-muscarinique et agoniste des oestrogenes pour traiter une vessie instable ou hyperactive |
US6517889B1 (en) | 2001-11-26 | 2003-02-11 | Swaminathan Jayaraman | Process for coating a surface of a stent |
US7488313B2 (en) | 2001-11-29 | 2009-02-10 | Boston Scientific Scimed, Inc. | Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment |
DE10200388A1 (de) | 2002-01-08 | 2003-07-24 | Translumina Gmbh | Beschichtungssystem |
CN1615137A (zh) | 2002-01-10 | 2005-05-11 | 诺瓦提斯公司 | 用于预防和治疗血管疾病、包含雷帕霉素及其衍生物的药物递送系统 |
US20030135256A1 (en) | 2002-01-14 | 2003-07-17 | Gallagher Brendan P. | Stent delivery system |
CN1279984C (zh) | 2002-02-15 | 2006-10-18 | Cv医药有限公司 | 用于医用装置的聚合物涂层 |
US20060093771A1 (en) | 2002-02-15 | 2006-05-04 | Frantisek Rypacek | Polymer coating for medical devices |
NZ534544A (en) | 2002-02-28 | 2007-05-31 | Novartis Ag | N- {5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl} -4-(3-pyridyl)-2-pyrimidine-amine coated stents |
AU2003228269A1 (en) | 2002-03-01 | 2003-09-16 | Mds Proteomics Inc. | Phosphorylated proteins and uses related thereto |
GB0205868D0 (en) | 2002-03-13 | 2002-04-24 | Univ Nottingham | Polymer composite with internally distributed deposition matter |
US7270675B2 (en) | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
US6669785B2 (en) | 2002-05-15 | 2003-12-30 | Micell Technologies, Inc. | Methods and compositions for etch cleaning microelectronic substrates in carbon dioxide |
DE60331731D1 (de) | 2002-05-28 | 2010-04-29 | Battelle Memorial Institute | Elektrostatische abscheidung von durch schnelle entspannung überkritischer lösungen (ress) erhaltene partikel |
TW200403065A (en) | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
US7229837B2 (en) | 2002-05-30 | 2007-06-12 | Uchicago Argonne, Llc | Enhanced photophysics of conjugated polymers |
US7638137B2 (en) | 2002-06-05 | 2009-12-29 | University Of Florida Research Foundation, Incorporated | Ophthalmic drug delivery system |
WO2003106543A1 (fr) | 2002-06-13 | 2003-12-24 | Kappler, Inc. | Membrane microporeuse a matiere de remplissage adsorbante et multifonctionnelle |
US6794902B2 (en) | 2002-06-14 | 2004-09-21 | Sun Microsystems, Inc. | Virtual ground circuit |
US7033602B1 (en) | 2002-06-21 | 2006-04-25 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7217426B1 (en) | 2002-06-21 | 2007-05-15 | Advanced Cardiovascular Systems, Inc. | Coatings containing polycationic peptides for cardiovascular therapy |
US6839913B2 (en) | 2002-06-25 | 2005-01-11 | Noble Ideas, Inc. | Adjustable garment waistband and method of manufacture |
CN100471469C (zh) | 2002-06-27 | 2009-03-25 | 微创医疗器械(上海)有限公司 | 一种具有多层涂层的药物洗脱支架 |
EP1516597A4 (fr) | 2002-06-27 | 2010-11-10 | Microport Medical Shanghai Co | Stent eluant des medicaments |
US20040013792A1 (en) | 2002-07-19 | 2004-01-22 | Samuel Epstein | Stent coating holders |
US7491233B1 (en) | 2002-07-19 | 2009-02-17 | Advanced Cardiovascular Systems Inc. | Purified polymers for coatings of implantable medical devices |
GB2391439B (en) | 2002-07-30 | 2006-06-21 | Wolfson Ltd | Bass compressor |
US7029495B2 (en) | 2002-08-28 | 2006-04-18 | Scimed Life Systems, Inc. | Medical devices and methods of making the same |
US7060051B2 (en) | 2002-09-24 | 2006-06-13 | Scimed Life Systems, Inc. | Multi-balloon catheter with hydrogel coating |
EP1549253A4 (fr) | 2002-09-26 | 2010-11-03 | Endovascular Devices Inc | Appareil et procede de distribution de mitomycine au moyen d'un dispositif medical d'elution biocompatible implantable |
US6702850B1 (en) | 2002-09-30 | 2004-03-09 | Mediplex Corporation Korea | Multi-coated drug-eluting stent for antithrombosis and antirestenosis |
US6800663B2 (en) | 2002-10-18 | 2004-10-05 | Alkermes Controlled Therapeutics Inc. Ii, | Crosslinked hydrogel copolymers |
KR100511030B1 (ko) | 2002-10-21 | 2005-08-31 | 한국과학기술연구원 | 혈액적합성 의료용 금속 재료 및 이의 제조 방법 |
US7462593B2 (en) | 2002-11-07 | 2008-12-09 | Us Gov Health & Human Serv | Compositions and methods for promoting angiogenesis |
US20050070989A1 (en) | 2002-11-13 | 2005-03-31 | Whye-Kei Lye | Medical devices having porous layers and methods for making the same |
US20040098106A1 (en) | 2002-11-14 | 2004-05-20 | Williams Michael S. | Intraluminal prostheses and carbon dioxide-assisted methods of impregnating same with pharmacological agents |
EP1567099A4 (fr) | 2002-11-15 | 2011-03-30 | Synecor Llc | Endoprotheses ameliorees et procedes de fabrication |
JP4987232B2 (ja) | 2002-11-18 | 2012-07-25 | ラットガーズ,ザ・ステート・ユニバーシティ・オブ・ニュージャージー | 新規のポリマーを用いた医療用デバイス |
JP4371653B2 (ja) | 2002-11-25 | 2009-11-25 | テルモ株式会社 | 体内埋込医療器具 |
US6790483B2 (en) | 2002-12-06 | 2004-09-14 | Eastman Kodak Company | Method for producing patterned deposition from compressed fluid |
US7094256B1 (en) | 2002-12-16 | 2006-08-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical device containing polycationic peptides |
WO2004060059A2 (fr) | 2002-12-23 | 2004-07-22 | Vical Incorporated | Procede de lyophilisation de complexes d'acide nucleique/copolymere sequence/tensioactif cationique |
US7152452B2 (en) | 2002-12-26 | 2006-12-26 | Advanced Cardiovascular Systems, Inc. | Assembly for crimping an intraluminal device and method of use |
US20040143317A1 (en) | 2003-01-17 | 2004-07-22 | Stinson Jonathan S. | Medical devices |
US7309349B2 (en) * | 2003-01-23 | 2007-12-18 | Cordis Corporation | Friction reducing lubricant for stent loading and stent delivery systems |
JP2004225126A (ja) | 2003-01-24 | 2004-08-12 | Pioneer Electronic Corp | 成膜用マスクとその製造方法 |
US20050079199A1 (en) | 2003-02-18 | 2005-04-14 | Medtronic, Inc. | Porous coatings for drug release from medical devices |
US20080051866A1 (en) | 2003-02-26 | 2008-02-28 | Chao Chin Chen | Drug delivery devices and methods |
WO2004075781A2 (fr) | 2003-02-26 | 2004-09-10 | Medivas, Llc | Endoprotheses vasculaires bioactives et leur mode d'emploi |
US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
US7326734B2 (en) | 2003-04-01 | 2008-02-05 | The Regents Of The University Of California | Treatment of bladder and urinary tract cancers |
US20060102871A1 (en) | 2003-04-08 | 2006-05-18 | Xingwu Wang | Novel composition |
US20050208102A1 (en) | 2003-04-09 | 2005-09-22 | Schultz Clyde L | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
US20050038498A1 (en) | 2003-04-17 | 2005-02-17 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
GB0310300D0 (en) | 2003-05-06 | 2003-06-11 | Univ Belfast | Nanocomposite drug delivery composition |
US7553827B2 (en) | 2003-08-13 | 2009-06-30 | Depuy Spine, Inc. | Transdiscal administration of cycline compounds |
US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
US7524527B2 (en) | 2003-05-19 | 2009-04-28 | Boston Scientific Scimed, Inc. | Electrostatic coating of a device |
US20040236416A1 (en) | 2003-05-20 | 2004-11-25 | Robert Falotico | Increased biocompatibility of implantable medical devices |
US7662864B2 (en) | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
WO2004108274A1 (fr) | 2003-06-06 | 2004-12-16 | Mitsubishi Chemical Corporation | Articles absorbant l'eau et procede de production de ces derniers |
WO2004113429A2 (fr) | 2003-06-23 | 2004-12-29 | The University Of Chicago | Nanocomposites polyoléfiniques |
US8399013B2 (en) | 2003-06-26 | 2013-03-19 | Poly-Med, Inc. | Partially absorbable fiber-reinforced composites for controlled drug delivery |
US7318945B2 (en) | 2003-07-09 | 2008-01-15 | Medtronic Vascular, Inc. | Laminated drug-polymer coated stent having dipped layers |
US7128277B2 (en) | 2003-07-29 | 2006-10-31 | Illinois Tool Works Inc. | Powder bell with secondary charging electrode |
US7169404B2 (en) | 2003-07-30 | 2007-01-30 | Advanced Cardiovasular Systems, Inc. | Biologically absorbable coatings for implantable devices and methods for fabricating the same |
US7056591B1 (en) | 2003-07-30 | 2006-06-06 | Advanced Cardiovascular Systems, Inc. | Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same |
US20050033417A1 (en) | 2003-07-31 | 2005-02-10 | John Borges | Coating for controlled release of a therapeutic agent |
WO2005011796A1 (fr) | 2003-08-05 | 2005-02-10 | Kaneka Corporation | Stent a mettre en place in vivo |
AP1899A (en) | 2003-08-08 | 2008-10-10 | Biovail Lab Int Srl | Modified-release tablet of bupropion hydrochloride |
EP1684820A2 (fr) | 2003-08-13 | 2006-08-02 | Medtronic, Inc. | Systemes de distribution d'agents actifs comprenant un melange de polymeres miscibles, dispositifs medicaux et procedes |
US7204560B2 (en) | 2003-08-15 | 2007-04-17 | Sandvik Intellectual Property Ab | Rotary cutting bit with material-deflecting ledge |
EP1656165B1 (fr) | 2003-08-19 | 2008-12-17 | PolyBioMed Limited | Systeme polymere de liberation de medicament pour dispositifs medicaux |
US7785653B2 (en) | 2003-09-22 | 2010-08-31 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US8801692B2 (en) | 2003-09-24 | 2014-08-12 | Medtronic Vascular, Inc. | Gradient coated stent and method of fabrication |
US20050070990A1 (en) | 2003-09-26 | 2005-03-31 | Stinson Jonathan S. | Medical devices and methods of making same |
US7744645B2 (en) | 2003-09-29 | 2010-06-29 | Medtronic Vascular, Inc. | Laminated drug-polymer coated stent with dipped and cured layers |
US7618647B2 (en) | 2003-10-03 | 2009-11-17 | Boston Scientific Scimed, Inc. | Using bucky paper as a therapeutic aid in medical applications |
US7329383B2 (en) | 2003-10-22 | 2008-02-12 | Boston Scientific Scimed, Inc. | Alloy compositions and devices including the compositions |
JP2007509220A (ja) | 2003-10-23 | 2007-04-12 | ユニバーシテイ・オブ・ノツテインガム | 活性ポリマー押出物の調製 |
US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
JP4618997B2 (ja) | 2003-12-09 | 2011-01-26 | テルモ株式会社 | ステントおよびその製造方法 |
DE602004009829T2 (de) | 2003-12-16 | 2008-08-21 | Cytec Surface Specialties, S.A. | Verfahren zum aufbringen einer beschichtung auf ein gewickeltes metallblech |
US20050131513A1 (en) | 2003-12-16 | 2005-06-16 | Cook Incorporated | Stent catheter with a permanently affixed conductor |
PT1699503E (pt) | 2003-12-24 | 2012-06-06 | Novartis Ag | Dispositivos revestidos com polímeros do tipo pec |
US20050268573A1 (en) | 2004-01-20 | 2005-12-08 | Avantec Vascular Corporation | Package of sensitive articles |
US7306677B2 (en) | 2004-01-30 | 2007-12-11 | Boston Scientific Corporation | Clamping fixture for coating stents, system using the fixture, and method of using the fixture |
GB2411078B (en) | 2004-02-10 | 2009-02-04 | Samsung Electronics Co Ltd | Mobile communications |
US8551512B2 (en) | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
CA2560507C (fr) | 2004-03-26 | 2011-08-16 | Surmodics, Inc. | Composition et procede permettant de preparer des surfaces biocompatibles |
US20050244459A1 (en) | 2004-04-06 | 2005-11-03 | Dewitt David M | Coating compositions for bioactive agents |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US20050288481A1 (en) | 2004-04-30 | 2005-12-29 | Desnoyer Jessica R | Design of poly(ester amides) for the control of agent-release from polymeric compositions |
WO2005117942A2 (fr) | 2004-05-14 | 2005-12-15 | The Regents Of The University Of Michigan | Procedes d'encapsulation de biomacromolecules dans des polymeres |
WO2006085898A1 (fr) | 2004-05-14 | 2006-08-17 | Becton, Dickinson & Company | Articles presentant des surfaces bioactives et procedes de preparation desdits articles sans solvant |
US7682656B2 (en) | 2004-06-14 | 2010-03-23 | Agruim Inc. | Process and apparatus for producing a coated product |
US7976557B2 (en) | 2004-06-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Cutting balloon and process |
US20060001011A1 (en) | 2004-07-02 | 2006-01-05 | Wilson Neil R | Surface conditioner for powder coating systems |
WO2006019904A1 (fr) | 2004-07-14 | 2006-02-23 | University Of Utha Research Foundation | Compositions et utilisations liées à des nétrines |
US8541078B2 (en) | 2004-08-06 | 2013-09-24 | Societe Bic | Fuel supplies for fuel cells |
US20060104969A1 (en) | 2004-08-16 | 2006-05-18 | Massachusetts Institute Of Technology | Compositions and methods for enhancing structural and functional nervous system reorganization and recovery |
US7425368B2 (en) | 2004-08-20 | 2008-09-16 | Massachusetts Institute Of Technology | Filler-enhanced polymeric fibers with improved mechanical properties and method for making |
US8119153B2 (en) | 2004-08-26 | 2012-02-21 | Boston Scientific Scimed, Inc. | Stents with drug eluting coatings |
JP5056013B2 (ja) | 2004-09-08 | 2012-10-24 | 株式会社カネカ | 生体留置用ステント |
JP4894519B2 (ja) | 2004-09-08 | 2012-03-14 | 株式会社カネカ | 生体留置用ステント |
WO2006036982A2 (fr) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Revetement d'administration de medicament pouvant etre utilise avec une endoprothese vasculaire |
US8313763B2 (en) | 2004-10-04 | 2012-11-20 | Tolmar Therapeutics, Inc. | Sustained delivery formulations of rapamycin compounds |
US20060093643A1 (en) | 2004-11-04 | 2006-05-04 | Stenzel Eric B | Medical device for delivering therapeutic agents over different time periods |
US7455658B2 (en) | 2004-11-10 | 2008-11-25 | Samw Hong Jen Wang | Fluid dispensing or feeding device |
US7455688B2 (en) * | 2004-11-12 | 2008-11-25 | Con Interventional Systems, Inc. | Ostial stent |
WO2006063021A2 (fr) | 2004-12-07 | 2006-06-15 | Surmodics, Inc. | Revetements comprenant un ou plusieurs agents actifs cristallises et methodes associees |
US7632307B2 (en) | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
US7727273B2 (en) | 2005-01-13 | 2010-06-01 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US7772352B2 (en) | 2005-01-28 | 2010-08-10 | Bezwada Biomedical Llc | Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices |
WO2006110197A2 (fr) | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Dispositif medical en polymere biodegradable |
US7837726B2 (en) | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
WO2006099276A2 (fr) | 2005-03-14 | 2006-09-21 | 3M Innovative Properties Company | Composes de polymeres biocompatibles pour preparations medicales |
EA200701998A1 (ru) | 2005-03-17 | 2008-02-28 | Элан Фарма Интернэшнл Лтд. | Композиции для инъекций наночастиц иммунодепрессивных соединений |
EP1868663B1 (fr) | 2005-03-23 | 2011-11-16 | Abbott Laboratories | Distribution d'agents hautement lipophiles au moyen de dispositifs medicaux |
US8628565B2 (en) | 2005-04-13 | 2014-01-14 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
WO2007011708A2 (fr) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent a revetement polymere renfermant de la rapamycine amorphe |
US20070026042A1 (en) | 2005-07-29 | 2007-02-01 | Narayanan Pallasssana V | System for treating aneurysmal disease |
US8377462B2 (en) | 2005-07-29 | 2013-02-19 | Advanced Cardiovascular Systems, Inc. | PEA-TEMPO/PEA-BZ coatings for controlled delivery of drug from implantable medical devices |
US7862848B2 (en) | 2005-08-03 | 2011-01-04 | The University Of Western Ontario | Direct coating solid dosage forms using powdered materials |
EP1911214B1 (fr) | 2005-08-05 | 2008-12-10 | Telecom Italia S.p.A. | Procédé d'établissement d'une connexion sur un réseau de communication |
WO2007017707A1 (fr) | 2005-08-11 | 2007-02-15 | Hilary Nwokeabia | Brosse a dents a poils en pente |
WO2007022055A1 (fr) | 2005-08-12 | 2007-02-22 | Massicotte J Mathieu | Procede et dispositif d'extraction d'objets du corps |
US20070043434A1 (en) | 2005-08-18 | 2007-02-22 | David Meerkin | Biodegradable endovascular stent using stereocomplexation of polymers |
EP1764116A1 (fr) | 2005-09-16 | 2007-03-21 | Debiotech S.A. | Production d'un revêtement poreux à l'aide des particules colloidales |
US7935379B2 (en) | 2005-11-14 | 2011-05-03 | Boston Scientific Scimed, Inc. | Coated and imprinted medical devices and methods of making the same |
DK1957130T3 (da) | 2005-12-09 | 2010-11-22 | Dsm Ip Assets Bv | Hydrofilt overtræk omfattende en polyelektrolyt |
US20070148251A1 (en) | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
US7842312B2 (en) | 2005-12-29 | 2010-11-30 | Cordis Corporation | Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
US8834912B2 (en) | 2005-12-30 | 2014-09-16 | Boston Scientific Scimed, Inc. | Medical devices having multiple charged layers |
US20080286325A1 (en) | 2006-01-05 | 2008-11-20 | Med Institute, Inc. | Cyclodextrin elution media for medical device coatings comprising a taxane therapeutic agent |
US7919108B2 (en) | 2006-03-10 | 2011-04-05 | Cook Incorporated | Taxane coatings for implantable medical devices |
JP5128497B2 (ja) | 2006-01-23 | 2013-01-23 | スミス アンド ネフュー インコーポレーテッド | 膝蓋構成要素 |
US20070299518A1 (en) | 2006-01-27 | 2007-12-27 | Med Institute, Inc. | Device with nanocomposite coating for controlled drug release |
WO2007089259A1 (fr) | 2006-02-02 | 2007-08-09 | The Johns Hopkins University | Compositions therapeutiques de fibres electrofilees |
JP4297221B2 (ja) | 2006-02-15 | 2009-07-15 | 株式会社ホソカワ粉体技術研究所 | 薬剤溶出型ステントの製造方法 |
US20070196242A1 (en) | 2006-02-23 | 2007-08-23 | Agamatrix, Inc. | Used test strip storage container |
US20070200268A1 (en) | 2006-02-24 | 2007-08-30 | Vipul Dave | Implantable device prepared from solution processing |
US8500772B2 (en) | 2006-03-20 | 2013-08-06 | Cook Medical Technologies Llc | Distal protection device |
US20070225795A1 (en) | 2006-03-24 | 2007-09-27 | Juan Granada | Composite vascular prosthesis |
US7955383B2 (en) | 2006-04-25 | 2011-06-07 | Medtronics Vascular, Inc. | Laminated implantable medical device having a metallic coating |
PL2019657T3 (pl) | 2006-04-26 | 2015-10-30 | Micell Technologies Inc | Powłoki zawierające wiele leków |
US7691400B2 (en) | 2006-05-05 | 2010-04-06 | Medtronic Vascular, Inc. | Medical device having coating with zeolite drug reservoirs |
US20080279909A1 (en) | 2006-05-12 | 2008-11-13 | Cleek Robert L | Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization |
US7959940B2 (en) | 2006-05-30 | 2011-06-14 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical devices |
US20070281117A1 (en) | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
BRPI0603437A2 (pt) | 2006-06-06 | 2010-07-06 | Luiz Gonzaga Granja Jr | prótese para anastomose tipo stent extraluminal |
US20080124372A1 (en) | 2006-06-06 | 2008-05-29 | Hossainy Syed F A | Morphology profiles for control of agent release rates from polymer matrices |
US8535372B1 (en) | 2006-06-16 | 2013-09-17 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with prohealing layer |
WO2008008291A2 (fr) | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
US7812032B2 (en) | 2006-07-25 | 2010-10-12 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
US7820812B2 (en) | 2006-07-25 | 2010-10-26 | Abbott Laboratories | Methods of manufacturing crystalline forms of rapamycin analogs |
WO2008024626A2 (fr) | 2006-08-21 | 2008-02-28 | Innovational Holdings Llc | Endoprothèse biorésorbable avec libération prolongée d'agent anti-resténose in vivo |
CN104906087A (zh) | 2006-09-13 | 2015-09-16 | 万能医药公司 | 大环内酯化合物及它们的使用方法 |
US20080065192A1 (en) | 2006-09-13 | 2008-03-13 | Medtronic Vascular, Inc. | Compliance Graded Stent |
US9402936B2 (en) | 2006-09-15 | 2016-08-02 | Boston Scientific Scimed, Inc. | Medical devices having alloy compositions |
WO2008036554A2 (fr) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprosthèses |
US8636767B2 (en) | 2006-10-02 | 2014-01-28 | Micell Technologies, Inc. | Surgical sutures having increased strength |
EP1913960A1 (fr) | 2006-10-19 | 2008-04-23 | Albert Schömig | implant enrobé |
EP1916006A1 (fr) | 2006-10-19 | 2008-04-30 | Albert Schömig | Implant revêtu de cire ou de résine |
US7959942B2 (en) | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
US20080097591A1 (en) | 2006-10-20 | 2008-04-24 | Biosensors International Group | Drug-delivery endovascular stent and method of use |
CN101678388B (zh) | 2006-10-23 | 2013-12-11 | 米歇尔技术公司 | 用于在涂覆过程中为基底充电的保持器 |
US20080098178A1 (en) | 2006-10-23 | 2008-04-24 | Veazey Judson E | Data storage on a switching system coupling multiple processors of a computer system |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
WO2008070996A1 (fr) | 2006-12-13 | 2008-06-19 | Angiotech Pharmaceuticals Inc. | Implants médicaux avec une combinaison de paclitaxel et de dipyridamole |
CA2679712C (fr) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents comportant des couches biodegradables |
US20130150943A1 (en) | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
ES2393639T3 (es) | 2007-01-21 | 2012-12-26 | Hemoteq Ag | Producto médico para tratar cierres de conductos corporales y prevención de nuevos cierres |
US7745566B2 (en) | 2007-01-23 | 2010-06-29 | Ferro Corporation | Methods for the purification of polymers |
US8401258B2 (en) | 2007-03-16 | 2013-03-19 | Sti Medical Systems, Llc | Method to provide automated quality feedback to imaging devices to achieve standardized imaging data |
US7815962B2 (en) | 2007-03-22 | 2010-10-19 | Medtronic Vascular, Inc. | Coated stent with evenly distributed therapeutic agent |
WO2008124634A1 (fr) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Micelles inverses encapsulées par un polymère |
AU2008242844A1 (en) | 2007-04-17 | 2008-10-30 | Micell Technologies, Inc. | Stents having biodegradable layers |
US9433516B2 (en) | 2007-04-17 | 2016-09-06 | Micell Technologies, Inc. | Stents having controlled elution |
WO2008137148A2 (fr) | 2007-05-03 | 2008-11-13 | Abraxis Bioscience, Llc | Procédés et compositions permettant le traitement de l'hypertension pulmonaire |
GB0709517D0 (en) | 2007-05-17 | 2007-06-27 | Queen Mary & Westfield College | An electrostatic spraying device and a method of electrostatic spraying |
WO2008144600A1 (fr) | 2007-05-17 | 2008-11-27 | Prescient Medical, Inc. | Systèmes de spectroscopie par fibres optiques multicanal utilisant des modules optiques intégrés |
EP2170418B1 (fr) | 2007-05-25 | 2016-03-16 | Micell Technologies, Inc. | Films de polymères pour le revêtement des dispositifs médicaux |
US7922760B2 (en) | 2007-05-29 | 2011-04-12 | Abbott Cardiovascular Systems Inc. | In situ trapping and delivery of agent by a stent having trans-strut depots |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US20090068266A1 (en) | 2007-09-11 | 2009-03-12 | Raheja Praveen | Sirolimus having specific particle size and pharmaceutical compositions thereof |
US20090076446A1 (en) | 2007-09-14 | 2009-03-19 | Quest Medical, Inc. | Adjustable catheter for dilation in the ear, nose or throat |
WO2009039553A1 (fr) | 2007-09-27 | 2009-04-02 | The Walter And Eliza Hall Institute Of Medical Research | Composés de benzothiazole |
US8709071B1 (en) | 2007-09-28 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Stent with preferential coating |
JP5114788B2 (ja) | 2007-09-28 | 2013-01-09 | 三菱重工業株式会社 | リチウム二次電池 |
US20090105687A1 (en) | 2007-10-05 | 2009-04-23 | Angioscore, Inc. | Scoring catheter with drug delivery membrane |
HUE055815T2 (hu) | 2007-10-05 | 2021-12-28 | Univ Wayne State | Vegyületek nyújtott felszabadítására alkalmas dendrimerek |
US20100298928A1 (en) | 2007-10-19 | 2010-11-25 | Micell Technologies, Inc. | Drug Coated Stents |
EP2997985A1 (fr) | 2007-10-30 | 2016-03-23 | Nanyang Technological University | Endoprothèse vasculaire non biodégradable comprenant un revêtement biodégradable et procédé de revêtement de celle-ci |
US8642062B2 (en) | 2007-10-31 | 2014-02-04 | Abbott Cardiovascular Systems Inc. | Implantable device having a slow dissolving polymer |
US20090111787A1 (en) | 2007-10-31 | 2009-04-30 | Florencia Lim | Polymer blends for drug delivery stent matrix with improved thermal stability |
CN101161300B (zh) | 2007-11-27 | 2011-03-16 | 北京美中双和医疗器械有限公司 | 三氧化二砷药物洗脱支架及其制备方法 |
US20090202609A1 (en) | 2008-01-06 | 2009-08-13 | Keough Steven J | Medical device with coating composition |
WO2009096822A1 (fr) | 2008-01-30 | 2009-08-06 | Micromuscle Ab | Dispositifs et procédés d'administration de médicament et leurs applications |
US20100042206A1 (en) | 2008-03-04 | 2010-02-18 | Icon Medical Corp. | Bioabsorbable coatings for medical devices |
US20090227948A1 (en) | 2008-03-06 | 2009-09-10 | Boston Scientific Scimed, Inc. | Balloon catheter devices with sheath covering |
EP2251050A4 (fr) | 2008-03-12 | 2013-08-14 | Anges Mg Inc | Cathéter de type à élution de médicament et procédé de fabrication du cathéter de type à élution de médicament |
EP2689789B1 (fr) | 2008-03-28 | 2019-03-13 | SurModics, Inc. | Dispositifs médicaux insérables présentant des substrats élastiques associés à des microparticules et procédés d'administration de médicaments |
MX2010011485A (es) | 2008-04-17 | 2011-03-01 | Micell Technologies Inc | Stents que contienen capas bioadsorbibles. |
US8557273B2 (en) | 2008-04-18 | 2013-10-15 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
US20110143429A1 (en) | 2008-04-30 | 2011-06-16 | Iksoo Chun | Tissue engineered blood vessels |
CN102017221B (zh) | 2008-05-08 | 2013-01-02 | 新日铁化学株式会社 | 有机场致发光元件用化合物及有机场致发光元件 |
US8298607B2 (en) | 2008-05-15 | 2012-10-30 | Abbott Cardiovascular Systems Inc. | Method for electrostatic coating of a medical device |
US7865562B2 (en) | 2008-05-20 | 2011-01-04 | International Business Machines Corporation | Selecting email signatures |
EP2131614B1 (fr) | 2008-05-30 | 2014-01-01 | Alcatel Lucent | Procédé de transmission de services de diffusion dans un réseau cellulaire de radiocommunication via une station de base femto, et station de base femto correspondante |
US20090297578A1 (en) | 2008-06-03 | 2009-12-03 | Trollsas Mikael O | Biosoluble coating comprising anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US20110189299A1 (en) | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
US7770466B2 (en) | 2008-07-02 | 2010-08-10 | Abbott Cardiovascular Systems Inc. | Method for measuring stent dislodgement force |
JP4557061B2 (ja) | 2008-07-11 | 2010-10-06 | トヨタ自動車株式会社 | ハイブリッド自動車およびその制御方法 |
AU2009270849B2 (en) | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
JP2010052503A (ja) | 2008-08-27 | 2010-03-11 | Kawano Terukazu | 船舶用エンジン |
US20100055145A1 (en) | 2008-08-29 | 2010-03-04 | Biosensors International Group | Stent coatings for reducing late stent thrombosis |
US8367090B2 (en) | 2008-09-05 | 2013-02-05 | Abbott Cardiovascular Systems Inc. | Coating on a balloon comprising a polymer and a drug |
AU2009293445A1 (en) | 2008-09-19 | 2010-03-25 | Innovative Surface Technologies, Inc. | Drug eluting superhydrophobic coatings |
EP2328523A2 (fr) | 2008-09-29 | 2011-06-08 | Robert Ndondo-Lay | Stent revêtu d'une matrice |
US8535655B2 (en) | 2008-10-10 | 2013-09-17 | Polyactiva Pty Ltd. | Biodegradable polymer—bioactive moiety conjugates |
US20120064143A1 (en) | 2008-11-11 | 2012-03-15 | The Board Of Regents Of The University Of Texas System | Inhibition of mammalian target of rapamycin |
US8333803B2 (en) | 2008-11-21 | 2012-12-18 | Lifecell Corporation | Reinforced biologic material |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
EP2384206B1 (fr) | 2008-12-26 | 2018-08-01 | Battelle Memorial Institute | Implants médicaux et procédés de fabrication associés |
US9572692B2 (en) | 2009-02-02 | 2017-02-21 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent that modulates plaque geometric morphology and chemical composition |
WO2010086863A2 (fr) | 2009-02-02 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Revêtements contenant un médicament cristallin |
US20100198330A1 (en) | 2009-02-02 | 2010-08-05 | Hossainy Syed F A | Bioabsorbable Stent And Treatment That Elicits Time-Varying Host-Material Response |
EP2411440B1 (fr) | 2009-03-23 | 2018-01-17 | Micell Technologies, Inc. | Polymères biodégradables améliorés |
WO2010111232A2 (fr) | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Dispositif médical d'administration de médicament |
EP2410954A4 (fr) | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | Endoprothèses périphériques dotées de couches |
JP2012522589A (ja) | 2009-04-01 | 2012-09-27 | ミシェル テクノロジーズ,インコーポレイテッド | 被覆ステント |
US20110301697A1 (en) | 2009-04-10 | 2011-12-08 | Hemoteq Ag | Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open |
US9492587B2 (en) | 2009-04-13 | 2016-11-15 | Abbott Cardiovascular Systems Inc. | Stent made from an ultra high molecular weight bioabsorbable polymer with high fatigue and fracture resistance |
US20100285085A1 (en) | 2009-05-07 | 2010-11-11 | Abbott Cardiovascular Systems Inc. | Balloon coating with drug transfer control via coating thickness |
WO2010135369A1 (fr) | 2009-05-18 | 2010-11-25 | Dose Medical Corporation | Implant oculaire à élution de médicament |
WO2010136604A1 (fr) | 2009-05-29 | 2010-12-02 | Dsm Ip Assets B.V. | Matrice de transfert pour le transfert d'un agent bioactif sur un tissu corporel |
EP2266507B1 (fr) | 2009-06-22 | 2015-07-29 | Biotronik VI Patent AG | Stent ayant un design amélioré |
US9327060B2 (en) | 2009-07-09 | 2016-05-03 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Rapamycin reservoir eluting stent |
US8039147B2 (en) | 2009-08-27 | 2011-10-18 | Sb Limotive Co., Ltd. | Rechargeable secondary battery having improved safety against puncture and collapse |
EP2531140B1 (fr) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Endoprothèse et système de pose d'endoprothèse avec une capacité améliorée de pose |
CN102883753B (zh) | 2010-03-25 | 2015-04-15 | 路通医疗股份有限公司 | 用于医疗设备的释药涂层 |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
WO2011123798A2 (fr) | 2010-04-01 | 2011-10-06 | The Johns Hopkins University | Renforts tridimensionnels, procédés pour les façonner et procédés de traitement d'une lésion des nerfs périphériques ou de la moelle épinière |
CA2794704C (fr) | 2010-04-16 | 2019-09-17 | Micell Technologies, Inc. | Endoprotheses vasculaires ayant une elution controlee |
EP2560576B1 (fr) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Endoprothèses et autres dispositifs ayant un revêtement de matrice extracellulaire |
WO2011140519A2 (fr) | 2010-05-07 | 2011-11-10 | Medicus Biosciences, Llc | Préformulation pharmaceutique se gélifiant in vivo |
EP2593039B1 (fr) | 2010-07-16 | 2022-11-30 | Micell Technologies, Inc. | Dispositif médical d'administration de médicament |
CA2810842C (fr) | 2010-09-09 | 2018-06-26 | Micell Technologies, Inc. | Formes pharmaceutiques de type macrolides |
WO2012078955A1 (fr) | 2010-12-10 | 2012-06-14 | Micropen Technologies Corporation | Endoprothèses et procédés de fabrication d'endoprothèses |
US8974622B2 (en) | 2010-12-28 | 2015-03-10 | Boston Scientific Scimed, Inc. | Composite ePTFE-silicone covering for stent |
CA2823355C (fr) | 2010-12-30 | 2017-08-22 | Micell Technologies, Inc. | Nanoparticules et revetements particulaires modifies en surface, ballonnets revetus et procedes associes |
WO2012097381A1 (fr) | 2011-01-14 | 2012-07-19 | Biomerix Corporation | Éléments matriciels élastomères réticulés au moins partiellement résorbables et leurs procédés de fabrication |
EP2696815B1 (fr) | 2011-04-13 | 2019-03-20 | Micell Technologies, Inc. | Endoprothèses présentant une élution régulée |
US20120280432A1 (en) | 2011-05-06 | 2012-11-08 | Industrial Technology Research Institute | Method for manufacturing bioabsorbable stents |
US9446172B2 (en) | 2011-05-10 | 2016-09-20 | Abbott Cardiovascular Systems Inc. | Modification of bioabsorbable stent to reduce thrombogenecity |
WO2012166819A1 (fr) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | Système et procédé de formation de revêtement transférable à élution de médicament, libéré dans le temps |
JP6505438B2 (ja) | 2011-06-30 | 2019-04-24 | エリクシアー メディカル コーポレイション | 生分解性内部人工器官およびその作製方法 |
CA2841360A1 (fr) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Dispositif medical d'administration de medicament |
US20140257465A1 (en) | 2011-08-12 | 2014-09-11 | Micell Technologies, Inc. | Stents having controlled elution |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
EP2768571B1 (fr) | 2011-10-18 | 2023-02-22 | Micell Technologies, Inc. | Dispositif médical d'administration de médicament |
WO2013177211A1 (fr) | 2012-05-21 | 2013-11-28 | Micell Technologies, Inc. | Endoprothèse à élution de médicament sûre dotée d'un enrobage absorbable |
JP2013153822A (ja) | 2012-01-27 | 2013-08-15 | Terumo Corp | 生体内留置用ステントおよび生体器官拡張器具 |
US9090029B2 (en) | 2012-02-06 | 2015-07-28 | Warsaw Orthopedic, Inc. | Pultrusion process for preparing composites having low percentage of fibers and articles made from same |
US8859088B2 (en) | 2012-04-16 | 2014-10-14 | Auburn University | Minimal weight composites using open structure |
US20150087671A1 (en) | 2012-05-16 | 2015-03-26 | Micell Technologies, Inc. | Low burst sustained release lipophilic and biologic agent compositions |
KR101231197B1 (ko) | 2012-09-20 | 2013-02-07 | 썬텍 주식회사 | 고분자 스텐트 |
AU2013331003B2 (en) | 2012-10-18 | 2016-11-24 | Micell Technologies, Inc. | Drug delivery medical device |
CN110269959A (zh) | 2013-03-12 | 2019-09-24 | 脉胜医疗技术公司 | 可生物吸收的生物医学植入物 |
CA2912387C (fr) | 2013-05-15 | 2019-04-16 | Micell Technologies, Inc. | Implants biomedicaux bioabsorbables |
-
2006
- 2006-07-14 WO PCT/US2006/027322 patent/WO2007011708A2/fr active Application Filing
- 2006-07-14 US US11/995,685 patent/US20090062909A1/en not_active Abandoned
-
2015
- 2015-05-21 US US14/718,342 patent/US10835396B2/en active Active
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3087860A (en) * | 1958-12-19 | 1963-04-30 | Abbott Lab | Method of prolonging release of drug from a precompressed solid carrier |
US3087660A (en) * | 1962-07-24 | 1963-04-30 | Yankee Plasties Inc | Two-step garment hanger |
US4326532A (en) * | 1980-10-06 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Antithrombogenic articles |
US4733665B1 (en) * | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US6409716B1 (en) * | 1989-12-15 | 2002-06-25 | Scimed Life Systems, Inc. | Drug delivery |
US5569463A (en) * | 1990-05-17 | 1996-10-29 | Harbor Medical Devices, Inc. | Medical device polymer |
US6524698B1 (en) * | 1990-09-27 | 2003-02-25 | Helmuth Schmoock | Fluid impermeable foil |
US5158986A (en) * | 1991-04-05 | 1992-10-27 | Massachusetts Institute Of Technology | Microcellular thermoplastic foamed with supercritical fluid |
US5356433A (en) * | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
US5243023A (en) * | 1991-08-28 | 1993-09-07 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Polyimides containing amide and perfluoroisopropylidene connecting groups |
US5342621A (en) * | 1992-09-15 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Antithrombogenic surface |
US5340614A (en) * | 1993-02-11 | 1994-08-23 | Minnesota Mining And Manufacturing Company | Methods of polymer impregnation |
US20020091433A1 (en) * | 1995-04-19 | 2002-07-11 | Ni Ding | Drug release coated stent |
US5948020A (en) * | 1995-05-01 | 1999-09-07 | Sam Yang Co., Ltd. | Implantable bioresorbable membrane and method for the preparation thereof |
US5873904A (en) * | 1995-06-07 | 1999-02-23 | Cook Incorporated | Silver implantable medical device |
US5824049A (en) * | 1995-06-07 | 1998-10-20 | Med Institute, Inc. | Coated implantable medical device |
US5811032A (en) * | 1995-09-19 | 1998-09-22 | Mitsubishi Gas Chemical Company, Inc. | Biodegradable water-soluble polymer |
US6461644B1 (en) * | 1996-03-25 | 2002-10-08 | Richard R. Jackson | Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods |
US6884377B1 (en) * | 1996-08-27 | 2005-04-26 | Trexel, Inc. | Method and apparatus for microcellular polymer extrusion |
US20050003074A1 (en) * | 1996-11-13 | 2005-01-06 | Phoqus Pharmaceuticals Limited | Method and apparatus for the coating of substrates for pharmaceutical use |
US6517860B1 (en) * | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
US6884823B1 (en) * | 1997-01-16 | 2005-04-26 | Trexel, Inc. | Injection molding of polymeric material |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6414050B1 (en) * | 1997-05-10 | 2002-07-02 | University Of Nottingham | Biofunctional polymers prepared in supercritical fluid |
US7378105B2 (en) * | 1997-09-26 | 2008-05-27 | Abbott Laboratories | Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens |
US6736996B1 (en) * | 1997-10-10 | 2004-05-18 | North Carolina State University | Compositions for protecting civil infrastructure |
US5957975A (en) * | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
US6838089B1 (en) * | 1998-04-14 | 2005-01-04 | Astrazeneca Ab | Antigen delivery system and method of production |
US6190699B1 (en) * | 1998-05-08 | 2001-02-20 | Nzl Corporation | Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa |
US6939569B1 (en) * | 1998-06-19 | 2005-09-06 | Oxibio, Inc. | Medical device having anti-infective and contraceptive properties |
US6372246B1 (en) * | 1998-12-16 | 2002-04-16 | Ortho-Mcneil Pharmaceutical, Inc. | Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
US6448315B1 (en) * | 1999-02-17 | 2002-09-10 | Bone Support Ab | Method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof |
US20040106982A1 (en) * | 1999-03-16 | 2004-06-03 | Jalisi Marc M. | Multilayer stent |
US6364903B2 (en) * | 1999-03-19 | 2002-04-02 | Meadox Medicals, Inc. | Polymer coated stent |
US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US6710059B1 (en) * | 1999-07-06 | 2004-03-23 | Endorecherche, Inc. | Methods of treating and/or suppressing weight gain |
US20020133072A1 (en) * | 1999-09-10 | 2002-09-19 | Guo-Bin Wang | Graft polymerization of substrate surfaces |
US6755871B2 (en) * | 1999-10-15 | 2004-06-29 | R.R. Street & Co. Inc. | Cleaning system utilizing an organic cleaning solvent and a pressurized fluid solvent |
US6767558B2 (en) * | 2000-03-10 | 2004-07-27 | Pfizer Inc. | Inhibiting oxidative degradation of pharmaceutical formulations |
US20070123977A1 (en) * | 2000-03-15 | 2007-05-31 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
US6627246B2 (en) * | 2000-05-16 | 2003-09-30 | Ortho-Mcneil Pharmaceutical, Inc. | Process for coating stents and other medical devices using super-critical carbon dioxide |
US6521258B1 (en) * | 2000-09-08 | 2003-02-18 | Ferro Corporation | Polymer matrices prepared by supercritical fluid processing techniques |
US6506213B1 (en) * | 2000-09-08 | 2003-01-14 | Ferro Corporation | Manufacturing orthopedic parts using supercritical fluid processing techniques |
US20060222756A1 (en) * | 2000-09-29 | 2006-10-05 | Cordis Corporation | Medical devices, drug coatings and methods of maintaining the drug coatings thereon |
US20050004661A1 (en) * | 2001-01-11 | 2005-01-06 | Lewis Andrew L | Stens with drug-containing amphiphilic polymer coating |
US6838528B2 (en) * | 2001-01-19 | 2005-01-04 | Nektar Therapeutics Al, Corporation | Multi-arm block copolymers as drug delivery vehicles |
US6897205B2 (en) * | 2001-01-31 | 2005-05-24 | Roehm Gmbh & Co. Kg | Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
US6905555B2 (en) * | 2001-02-15 | 2005-06-14 | Micell Technologies, Inc. | Methods for transferring supercritical fluids in microelectronic and other industrial processes |
US6720003B2 (en) * | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
US20030180376A1 (en) * | 2001-03-02 | 2003-09-25 | Dalal Paresh S. | Porous beta-tricalcium phosphate granules and methods for producing same |
US20030143315A1 (en) * | 2001-05-16 | 2003-07-31 | Pui David Y H | Coating medical devices |
US7163715B1 (en) * | 2001-06-12 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Spray processing of porous medical devices |
US20030125800A1 (en) * | 2001-11-05 | 2003-07-03 | Shulze John E. | Drug-delivery endovascular stent and method for treating restenosis |
US20030088307A1 (en) * | 2001-11-05 | 2003-05-08 | Shulze John E. | Potent coatings for stents |
US6868123B2 (en) * | 2001-12-07 | 2005-03-15 | Motorola, Inc. | Programmable motion estimation module with vector array unit |
US6837611B2 (en) * | 2001-12-28 | 2005-01-04 | Metal Industries Research & Development Centre | Fluid driven agitator used in densified gas cleaning system |
US20060121089A1 (en) * | 2002-03-20 | 2006-06-08 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices |
US20030185964A1 (en) * | 2002-03-28 | 2003-10-02 | Jan Weber | Method for spray-coating a medical device having a tubular wall such as a stent |
US20030204238A1 (en) * | 2002-04-26 | 2003-10-30 | Eugene Tedeschi | Coated stent with crimpable coating |
US6780475B2 (en) * | 2002-05-28 | 2004-08-24 | Battelle Memorial Institute | Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions |
US6749902B2 (en) * | 2002-05-28 | 2004-06-15 | Battelle Memorial Institute | Methods for producing films using supercritical fluid |
US6756084B2 (en) * | 2002-05-28 | 2004-06-29 | Battelle Memorial Institute | Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions |
US20040126542A1 (en) * | 2002-07-29 | 2004-07-01 | Nitto Denko Corporation | Pressure-sensitive adhesive tape or sheet |
US20050019747A1 (en) * | 2002-08-07 | 2005-01-27 | Anderson Daniel G. | Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
US20030031699A1 (en) * | 2002-09-30 | 2003-02-13 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
US20050010275A1 (en) * | 2002-10-11 | 2005-01-13 | Sahatjian Ronald A. | Implantable medical devices |
US20060193886A1 (en) * | 2002-11-13 | 2006-08-31 | Owens Gary K | Medical devices with nanoporous layers and topcoats |
US20060193890A1 (en) * | 2002-11-13 | 2006-08-31 | Owens Gary K | Method for loading nanoporous layers with therapeutic agent |
US20040193262A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US20040193177A1 (en) * | 2003-03-31 | 2004-09-30 | Houghton Michael J. | Modified delivery device for coated medical devices |
US20050191491A1 (en) * | 2003-04-08 | 2005-09-01 | Yulu Wang | Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process |
US20050216075A1 (en) * | 2003-04-08 | 2005-09-29 | Xingwu Wang | Materials and devices of enhanced electromagnetic transparency |
US20050196424A1 (en) * | 2003-05-02 | 2005-09-08 | Chappa Ralph A. | Medical devices and methods for producing the same |
US20080118543A1 (en) * | 2003-05-08 | 2008-05-22 | Advanced Cardiovascular Systems, Inc. | Stent Coatings comprising hydrophilic additives |
US7279174B2 (en) * | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
US20050015046A1 (en) * | 2003-07-18 | 2005-01-20 | Scimed Life Systems, Inc. | Medical devices and processes for preparing same |
US20050049694A1 (en) * | 2003-08-07 | 2005-03-03 | Medtronic Ave. | Extrusion process for coating stents |
US20050177223A1 (en) * | 2003-09-18 | 2005-08-11 | Palmaz Julio C. | Medical devices having MEMs functionality and methods of making same |
US20050069630A1 (en) * | 2003-09-30 | 2005-03-31 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US20050079274A1 (en) * | 2003-10-14 | 2005-04-14 | Maria Palasis | Method for coating multiple stents |
US20050147734A1 (en) * | 2004-01-07 | 2005-07-07 | Jan Seppala | Method and system for coating tubular medical devices |
US20050175772A1 (en) * | 2004-02-10 | 2005-08-11 | Robert Worsham | Apparatus and method for electrostatic spray coating of medical devices |
US20050238829A1 (en) * | 2004-04-22 | 2005-10-27 | John Motherwell | Differentially coated medical devices, system for differentially coating medical devices, and coating method |
US20060020325A1 (en) * | 2004-07-26 | 2006-01-26 | Robert Burgermeister | Material for high strength, controlled recoil stent |
US20060094744A1 (en) * | 2004-09-29 | 2006-05-04 | Maryanoff Cynthia A | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
US20060134211A1 (en) * | 2004-12-16 | 2006-06-22 | Miv Therapeutics Inc. | Multi-layer drug delivery device and method of manufacturing same |
US20060136041A1 (en) * | 2004-12-17 | 2006-06-22 | Schmid Eric V | Slide-and-lock stent |
US20060198868A1 (en) * | 2005-01-05 | 2006-09-07 | Dewitt David M | Biodegradable coating compositions comprising blends |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US20070196423A1 (en) * | 2005-11-21 | 2007-08-23 | Med Institute, Inc. | Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent |
US20070203569A1 (en) * | 2006-02-24 | 2007-08-30 | Robert Burgermeister | Implantable device formed from polymer blends having modified molecular structures |
US20080075753A1 (en) * | 2006-09-25 | 2008-03-27 | Chappa Ralph A | Multi-layered coatings and methods for controlling elution of active agents |
US20080255510A1 (en) * | 2006-11-20 | 2008-10-16 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US20080213464A1 (en) * | 2007-01-03 | 2008-09-04 | Boston Scientific Scimed, Inc. | Methods of applying coating to the inside surface of a stent |
US20080206304A1 (en) * | 2007-02-27 | 2008-08-28 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions based on styrene-isobutylene copolymers |
US20090105809A1 (en) * | 2007-10-19 | 2009-04-23 | Lee Michael J | Implantable and lumen-supporting stents and related methods of manufacture and use |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10835396B2 (en) | 2005-07-15 | 2020-11-17 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US20090123515A1 (en) * | 2005-07-15 | 2009-05-14 | Doug Taylor | Polymer coatings containing drug powder of controlled morphology |
US10898353B2 (en) | 2005-07-15 | 2021-01-26 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
US9827117B2 (en) | 2005-07-15 | 2017-11-28 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
US8758429B2 (en) | 2005-07-15 | 2014-06-24 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
US11911301B2 (en) | 2005-07-15 | 2024-02-27 | Micell Medtech Inc. | Polymer coatings containing drug powder of controlled morphology |
US8852625B2 (en) | 2006-04-26 | 2014-10-07 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US9415142B2 (en) | 2006-04-26 | 2016-08-16 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US11850333B2 (en) | 2006-04-26 | 2023-12-26 | Micell Medtech Inc. | Coatings containing multiple drugs |
US11007307B2 (en) | 2006-04-26 | 2021-05-18 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US9737645B2 (en) | 2006-04-26 | 2017-08-22 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US20090186069A1 (en) * | 2006-04-26 | 2009-07-23 | Micell Technologies, Inc. | Coatings Containing Multiple Drugs |
US20100030261A1 (en) * | 2006-10-02 | 2010-02-04 | Micell Technologies, Inc. | Surgical Sutures Having Increased Strength |
US8636767B2 (en) | 2006-10-02 | 2014-01-28 | Micell Technologies, Inc. | Surgical sutures having increased strength |
US9539593B2 (en) | 2006-10-23 | 2017-01-10 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
US20080095919A1 (en) * | 2006-10-23 | 2008-04-24 | Mcclain James B | Holder For Electrically Charging A Substrate During Coating |
US10617795B2 (en) | 2007-01-08 | 2020-04-14 | Micell Technologies, Inc. | Stents having biodegradable layers |
US20100063580A1 (en) * | 2007-01-08 | 2010-03-11 | Mcclain James B | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
US9737642B2 (en) * | 2007-01-08 | 2017-08-22 | Micell Technologies, Inc. | Stents having biodegradable layers |
US20100272778A1 (en) * | 2007-04-17 | 2010-10-28 | Micell Technologies, Inc. | Stents having controlled elution |
US9775729B2 (en) | 2007-04-17 | 2017-10-03 | Micell Technologies, Inc. | Stents having controlled elution |
US20100211164A1 (en) * | 2007-04-17 | 2010-08-19 | Mcclain James B | Stents having biodegradable layers |
US9433516B2 (en) | 2007-04-17 | 2016-09-06 | Micell Technologies, Inc. | Stents having controlled elution |
US9486338B2 (en) | 2007-04-17 | 2016-11-08 | Micell Technologies, Inc. | Stents having controlled elution |
US20100228348A1 (en) * | 2007-05-25 | 2010-09-09 | Micell Technologies, Inc. | Polymer Films for Medical Device Coating |
US8900651B2 (en) | 2007-05-25 | 2014-12-02 | Micell Technologies, Inc. | Polymer films for medical device coating |
US20100298928A1 (en) * | 2007-10-19 | 2010-11-25 | Micell Technologies, Inc. | Drug Coated Stents |
US10350333B2 (en) | 2008-04-17 | 2019-07-16 | Micell Technologies, Inc. | Stents having bioabsorable layers |
US20090292351A1 (en) * | 2008-04-17 | 2009-11-26 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
US9789233B2 (en) | 2008-04-17 | 2017-10-17 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
US9486431B2 (en) | 2008-07-17 | 2016-11-08 | Micell Technologies, Inc. | Drug delivery medical device |
US9981071B2 (en) | 2008-07-17 | 2018-05-29 | Micell Technologies, Inc. | Drug delivery medical device |
US20100015200A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug Delivery Medical Device |
US10350391B2 (en) | 2008-07-17 | 2019-07-16 | Micell Technologies, Inc. | Drug delivery medical device |
US20110159069A1 (en) * | 2008-12-26 | 2011-06-30 | Shaw Wendy J | Medical Implants and Methods of Making Medical Implants |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
US20100239635A1 (en) * | 2009-03-23 | 2010-09-23 | Micell Technologies, Inc. | Drug delivery medical device |
US20100241220A1 (en) * | 2009-03-23 | 2010-09-23 | Mcclain James B | Peripheral Stents Having Layers |
US20100256746A1 (en) * | 2009-03-23 | 2010-10-07 | Micell Technologies, Inc. | Biodegradable polymers |
US20100256748A1 (en) * | 2009-04-01 | 2010-10-07 | Micell Technologies, Inc. | Coated stents |
US9981072B2 (en) | 2009-04-01 | 2018-05-29 | Micell Technologies, Inc. | Coated stents |
US10653820B2 (en) | 2009-04-01 | 2020-05-19 | Micell Technologies, Inc. | Coated stents |
US11369498B2 (en) * | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
US20110190864A1 (en) * | 2010-02-02 | 2011-08-04 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US20110238161A1 (en) * | 2010-03-26 | 2011-09-29 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
US9687864B2 (en) | 2010-03-26 | 2017-06-27 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
WO2011130448A1 (fr) * | 2010-04-16 | 2011-10-20 | Micell Technologies, Inc. | Endoprothèses vasculaires ayant une élution contrôlée |
US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
US11904118B2 (en) | 2010-07-16 | 2024-02-20 | Micell Medtech Inc. | Drug delivery medical device |
US10293050B2 (en) | 2010-09-09 | 2019-05-21 | Micell Technologies, Inc. | Macrolide dosage forms |
US9636309B2 (en) | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US10729819B2 (en) | 2011-07-15 | 2020-08-04 | Micell Technologies, Inc. | Drug delivery medical device |
US10117972B2 (en) | 2011-07-15 | 2018-11-06 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
US11039943B2 (en) | 2013-03-12 | 2021-06-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
US10272606B2 (en) | 2013-05-15 | 2019-04-30 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
Also Published As
Publication number | Publication date |
---|---|
US20160015537A1 (en) | 2016-01-21 |
US10835396B2 (en) | 2020-11-17 |
WO2007011708A3 (fr) | 2007-06-28 |
WO2007011708A8 (fr) | 2007-04-26 |
WO2007011708A2 (fr) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10835396B2 (en) | Stent with polymer coating containing amorphous rapamycin | |
CA2697239C (fr) | Procede et systeme de revetement d'une surface d'un dispositif medical avec un agent therapeutique et dispositifs medicaux d'elution de medicament constitues par ceux-ci | |
Steckel et al. | Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide | |
Martin et al. | Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology | |
JP3986086B2 (ja) | 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法 | |
US6730349B2 (en) | Mechanical and acoustical suspension coating of medical implants | |
EP1909973B1 (fr) | Enrobages polymeres renfermant de la poudre de medicament a morphologie commandee | |
US6368658B1 (en) | Coating medical devices using air suspension | |
US5833891A (en) | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents | |
EP1368131B1 (fr) | Dispositif et procede de protection de dispositifs medicaux durant une operation de revetement | |
Thies et al. | A supercritical fluid-based coating technology 1: Process considerations | |
JPH0419910B2 (fr) | ||
EP2616113B1 (fr) | Procédés pour charger un dispositif médical d'élution | |
EP2616111B1 (fr) | Appareil et procédé pour le chargement d'un dispositif médical d'élution d'un médicament | |
Lo Porto et al. | On the plasma deposition of vancomycin‐containing nano‐capsules for drug‐delivery applications | |
US5075257A (en) | Aerosol deposition and film formation of silicon | |
CN108261569B (zh) | 药物球囊的制备方法 | |
MXPA04010018A (es) | Aerosol que contiene una substancia activa compuesta de particulas. | |
EP1183018A1 (fr) | Procedes de revetement de particules et particules ainsi produites | |
JP2003526653A (ja) | 圧縮流体を用いた急速放出製剤の調製方法 | |
JP2004193612A (ja) | 可動基板上にパターン化されたデポジションを製作するシステム | |
CA2544376A1 (fr) | Procede de preparation de dispositifs medicaux pour l'elution de medicaments | |
WO2009081048A2 (fr) | Desensibilisation par enrobage de cristaux de substances energetiques explosives; cristaux de telles substances enrobes; materiaux energetiques. | |
US8357251B2 (en) | Powder processing method | |
KR20150083841A (ko) | 치료제의 서방을 위한 다층 생분해성 미세입자 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MICELL TECHNOLOGIES, INC., NORTH CAROLINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAYLOR, DOUG;DEYOUNG, JAMES;MCCLAIN, JIM;REEL/FRAME:021102/0582;SIGNING DATES FROM 20080611 TO 20080613 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |